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CHAPTER I
INTRODUCTION 
Contamination of Escherichia coli O157:H7 is the main microbiological 
food safety concern of the beef industry.  At the 2003 National Meat 
Association’s annual meeting, Dr. Dell Allen (Vice President of Technical 
Services and Food Safety at Cargill Meat Solutions) stated, “There is no silver 
bullet.  Get that idea through your head.  We are going to have this bug (E. coli 
O157:H7) forever” (Meat News, 2005).  The meat industry has accepted the ever 
presence of E. coli O157:H7 and has implemented Hazard Analysis Critical 
Control Point (HACCP) plans, and introduced interventions to reduce the 
occurrence of this elusive and troublesome pathogen (NCBA, 2005c). 
Every outbreak of E. coli O157:H7 causes sickness, hospitalization and/or 
even death (NCBA, 2005b).  This pathogen continues to plague the beef 
industry, and has emerged as a major public health concern (Padhye and Doyle, 
1991).  Outbreaks result in loss of trust and confidence in beef products and the 
industry (NCBA, 2005a).  Economists report, every outbreak and product recall 
results in a decline in beef demand, and boneless beef prices to decrease two to 
two and one half percent in value (NCBA, 2005b).  Furthermore, agricultural 
economists estimated food safety recalls from 1991 to 1999 cost the beef 
industry a staggering $1.6 billion as a result of decrease consumer (NCBA, 
2005b).  The NCBA (2005a,b) has funded over $20 million dollars from the 
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check-off over the past decade to attack this persistent food pathogen problem.  
Additionally, the NCBA (2005b) estimated over $500 million have been spent by 
the 30 largest beef packers in the United States on food safety research,  not 
included is an  increase in operating cost of $250 million due to compliance with 
food safety regulations and plant improvement for food safety (NCBA, 2005a).  
The estimated total cost of E. coli O157:H7 the beef industry is in excess of $2.6 
billion during the past ten years (NCBA, 2005a). 
The overwhelming financial impact of E. coli O157:H7 has led to reforms 
by the meat industry and beef cattle suppliers.  During the past decade, industry 
leaders have developed guidelines, clarified critical control points (CCP) and 
interventions for every segment of the beef industry to reduce and eliminate E. 
coli O157:H7.  The industry ha explored and added new interventions to 
eliminate the chance of microbial contamination.  Despite the industry’s best 
efforts, consumers often fail to accept their role in the equation of food safety 
(Doores, 1999).  Smith (2000) reported shoppers fail to maintain proper 
temperatures of beef products.  In extreme cases, products remained 
unrefrigerated in excess of 2 hours.  Everyone involved, rancher to consumer, 
must take responsibility to minimize foodborne illnesses. 
 In early 2005, the USDA’s Food Safety and Inspection Service (FSIS) 
reported, the beef industry’s efforts against E. coli O157:H7 are beginning to pay 
off.  Positive ground beef samples have decreased by 43.3% from 2003 to 2004, 
and more than 80% from the year 2000 (NCBA, 2005c).  Furthermore, the 
number of E. coli O157:H7 recalls has declined with twenty-one in 2002, twelve 
    3 
in 2003, and six in 2004 (NCBA, 2005c).  Elimination of E. coli O157:H7 or other 
pathogens from the beef supply is an unattainable goal.  Nonetheless, through 
implementation of innovative ideas, pathogens have been greatly reduced and 
outbreaks have occurred less frequently than in previous years. 
 The beef industry’s most common microbial interventions for beef 
carcasses include organic acid rinses, hot water washes, high pressure water 
washes, and steam pasteurization.  In 2001, Dr. A. S. Naidu developed a all 
natural microbial spray based upon lactoferrin’s antimicrobial properties.  Dr. 
Naidu’s patented formula optimizes lactoferrin’s antimicrobial effectiveness 
(Naidu, 2002).  Currently, this technology is marketed by aLF Ventures as 
Activin.  National Beef Packing Company applies Activin to every beef carcass 
processed in their facilities.  Activin has been proven in laboratory settings, yet 
Activin’s antimicrobial effectiveness has not been tested under commercial 
conditions on beef tissues. 
This research had three objectives.  The first evaluated the efficacy of 
Activin as a post-harvest intervention against a hot water treatment, high 
pressure treatment and a lactic acid treatment on E. coli O157:H7 inoculated on 
adipose tissue. The second objective determined if the National Beef Packing 
Company’s sequential multi-hurdle intervention sequence containing Activin was 
superior in reducing E. coli O157:H7 on adipose and lean tissue to the identical 
intervention process without Activin.  The concluding objective examined the 
effect Activin in a multi-hurdle sequence has on total plate counts, Coliform 
counts, Enterobacteriaceae, and Lactic acid bacteria on lean and adipose tissue 
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over a 7 d refrigerated (7° C) storage period compared to the identical sequence 
without Activin.  
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CHAPTER II
REVIEW OF LITERATURE 
Escherichia coli O157:H7 
 Escherichia coli (E. coli) of the bacterial family Enterobacteriaceae is 
commonly found in the intestines of healthy animals as well as in humans.  Non-
pathogenic E. coli has been found to suppress the growth of harmful bacteria 
species and synthesize vitamins in the intestines (US FDA, 2005).  However, a 
few strains of E. coli commonly isolated in the environment are pathogenic, the 
most well known being E. coli O157:H7 (Johnson et al., 1983; Padhye et al., 
1986; Reed, 1994; Kassenborg et al., 2004; USFDA, 2005).  All E. coli strains 
are gram negative, rod shaped, facultative anaerobes that ferment lactose and 
do not produce spores.  The optimum growth temperature of E. coli O157:H7 is 
37° C, yet studies have shown survival in extremely cold environments (-20° C) 
for up to 9 months, as well as survive in pH’s as low as 4.5 (Gorman et al., 1995; 
Glass et al., 1992; Griffin and Tauxe, 1991; Doyle, 1991, Raghubeer and 
Matches, 1990; Wells et al., 1983; Jay, 1986; Doyle and Schoenei, 1984).  
Furthermore, E. coli O157:H7 has been reported as being able to survive on 
surfaces and in soils for extended periods of time (>6 months) (Varma et al., 
2003).  Despite being able to survive in these extreme cases, E. coli O157:H7 
cannot survive in conditions above 60° C, and cooking recommendations for 
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ground beef require an internal temperature to exceed 71° C (Line et al., 1991; 
USDA, 2005a).   
When ingested, E. coli O157:H7 attaches to the epithelial lining of the 
intestinal tract, and produces a verotoxin (verotoxin 1, 2, or 3), closely related to 
the toxin produced by Shigella dysenteriae (US FDA, 2005; Johnson et al., 1983; 
Padhye et al., 1986).  The resulting illness is hemorrhagic colitis (US FDA, 2005).  
Very little is known about the actual dose needed to produce the illness, but it is 
thought to be similar to Shigella ssp., requiring 10 organisms (US FDA, 2005).  
Hemorrhagic colitis has the following symptoms: 
  Severe abdominal cramping 
  Diarrhea which is initially watery and can become bloody 
  Vomiting may occur 
  Low fever or none at all 
  Usually lasts 2 to 9 days. 
The illness is self-limiting lasting an average of eight days. The most 
susceptible individuals are the very young, elderly and those whom have a 
compromised immune system (US FDA, 2005).  In these individuals hemorrhagic 
colitis may develop into hemolytic uremic syndrome (HUS), thrombotic 
thrombocytopenic purpura (TTP), or result in acute renal failure (US FDA, 2005; 
Padhye and Doyle, 1991, Riley, 1987).   
The true frequency of illness caused by E. coli O157:H7 is not known 
because most cases are unreported.  Nonetheless, the Centers for Disease 
Control and Prevention (CDC, 2005) estimate that 73,000 cases of E. coli 
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O157:H7 occur every year in the United States. Of those, 2,100 people are 
hospitalized, and 61 people die as a direct result of E. coli O157:H7 infections 
and complications.  Recently, the CDC (2005) concluded that E. coli O157:H7 
infections declined by 36% in the past year (Figure1).  The annual cost of E. coli 
O157:H7 related foodborne illnesses is estimated at $659.1 million (USDA ERS, 
2005).  This doesn’t include monetary value of death or the value of not being 
able to return to work (USDA ERS, 2005).  Moreover, the value also doesn’t 
account for the costs associated with product testing, facility upgrades, recalls 
and loss of product value due to positive results in the product and decline in 
value associated with outbreaks 
 
Figure 1: Reported Cases of E. coli O157:H7, United States 1994-2005.  
(MMWR, 2005)  
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According to the CDC, E. coli O157:H7 illness cases were not nationally 
notifiable until 1994 (CDC, 2005).  Nonetheless, the pathogen has been a 
concern to the meats industry for over 2 decades.  The first of over one hundred 
outbreaks occurred in 1982 (Arthur et al., 2004).  This includes the most known 
“Jack in the Box” outbreaks of 1992 and 1993 which resulted in hundreds of 
illnesses and four deaths related to E. coli O157:H7 (Arthur et al., 2004; Tuttle et 
al., 1999; Riley et al., 1983).  Only 52% of the outbreaks have been linked to 
beef, yet beef is characterized as the primary reservoir of E. coli O157:H7 (Elder 
et al., 2000).  In 1993, E. coli O157:H7 was declared as an adulterant in meat 
products and control of the pathogen was to be implemented into every HACCP 
plan (USDA FSIS, 1996). 
 E. coli O157:H7 has been researched extensively in commercial beef 
production from farm to table during the past decade.  The majority of the 
research conducted related to prevention of contamination, source of 
contamination and possible indicator organisms to predict the presence of E. coli 
O157:H7 with other bacteria (Arthur et al., 2004; Allen, 2004; Elder et al., 2000).  
E. coli O157:H7 peak shedding rates occur during the summer and early fall 
resulting in a high number of positives in lots, on hides, carcasses and illness 
cases reported to the CDC (Elder et al., 2000; CDC, 2005).  According to Dr. Dell 
Allen (2004), retired Vice-President of Quality and Training Cargill Meat Solutions 
(Wichita, KS), in June 2003, over one million dollars of product value was lost 
due to E. coli O157:H7 positives in ground beef at one Cargill Meat Solutions 
beef plant.  E. coli O157:H7 positives vary between lots of animals and plants for 
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several reasons: cleanliness of cattle, the incidence of cattle actually carrying the 
organism, skill of employees, microbial interventions in placed, number of 
microbial interventions, region, sampling technique and design of facility (Elder et 
al., 2000; Arthur, et al., 2003; Allen, 2004).   
In the past ten years the beef industry has became self-motivated to 
prevent the problem. They have accepted the never ending presence of E. coli 
O157:H7 and other pathogenic micro-organisms.  However, there has been no 
“silver bullet” discovered and outbreaks cause negative publicity the beef industry 
cannot afford.  Economic costs have been estimated for the treatment of those 
who acquire the disease, but it is hard to estimate the economic loss of 
individuals not consuming beef due to fear of illness. 
Bacterial Attachment 
The mechanism of attachment of bacteria to animal tissues is very 
complex and not well understood (Firstenberg-Eden, 1981).  Attachment is 
believed to occur in two stages.  First, cells become associated through a loose 
reversible absorption, using London-van-der-Waals interactions.  London-van-
der-Waals binding is a weak interaction due to the  electrical repulsive energies 
between two surfaces and electrical repulsive energies resulting from 
overlapping ionic atmospheres around the surface (Firstenberg-Eden, 1981).  
The second phase is irreversible attachment of bacteria to the surface.  
Irreversible attachment is achieved through fimbriae, pili, hydrogen bonds, ionic 
bonds or formation of extra cellular polysaccharides (Firstenberg-Eden, 1981).  
Costerton et al. (1978) claims bacteria attach strongly to a surface with a mass of 
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tangled fibers of polysaccharides forming the “glycocalyx” that surrounds the cell 
or the colony.  The glycocalyx is formed by cells which have been stressed.  The 
glycocalyx channels nutrients and aids in the regulation of the cell’s digestive 
enzymes (Firstenberg-Eden, 1981).  Attachment of bacteria stops 20-30 minutes 
following inoculation of surfaces (Notermans and Kampelmacher, 1975; 
Firstenberg-Eden, 1981). 
 Attachment of microorganisms depends on many known and unknown 
factors.  The attachment of microorganisms depends on bacterial species 
(Chung et al., 1989), inoculum concentration (Notermans and Kampelmacher 
1975; Butler et al., 1979; Firstenberg-Eden, 1981), temperature of attachment 
medium (Butler et al., 1979), type of meat or tissue (Firstenberg-Eden et al., 
1978), structure and morphology (Butler et al., 1979).  Conflicting research adds 
to complexity of bacterial attachment, for example studies show that E. coli 
O157:H7, Listeria Monocytogenes, Salmonella spp. and Staphylococcus aureus 
have similar attachment rates to both lean and fat tissues (Chung et al., 1989;  
Cabedo et al., 1997).  However, Firstenberg-Eden et al., (1978) reported 
difference in attachment due to species of bacteria and tissue types.  
Furthermore, there is a positive linear relationship between the inoculum 
concentration and, the number of bacteria that attach. After an attachment 
period, some bacteria are loosely attached and wash away due their association 
with the aqueous solution (Firstenberg-Eden, 1981).  The tissue type has shown 
to effect the attachment of bacteria, but Cabedo et al., (1997) found that E. coli 
O157:H7 attached at the same rate to both beef muscle and adipose tissues.  
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However, they reported an unexplained variation in the detachment of the 
microorganism from the two surfaces. in which bacteria seemed to have a 
stronger attachment to adipose tissue.  However, Dickson (1998) reported 
Listeria monocytogenes, S. tryphimurium, S. aureus and S. marcescens were 
effectively removed when washed from adipose tissue with solutions, than from 
beef muscle.  Dickson (1998) also, suggested  collagen caused a stronger 
attachment to muscle than to adipose tissue.  Motile species of bacteria which 
have flagella and fimbriae more readily attach than that of non-motile species of 
bacteria (Butler et al., 1979).  Several studies have found motility helps move the 
bacteria to the surface for attachment to occur.  Notermans and Kampelmacher 
(1975) concluded that flagella had a critical role in attachment, while McMeekin 
and Thomas (1978) disagreed and claimed flagella played no role in bacterial 
attachment.  Costerton et al. (1981) reported that the polysaccharide structure, 
glycocalyx, formed only in bacteria which were stressed for nutrients.  However, 
Cabedo et al. (1997) stated there was no difference in attachment due to 
restriction of nutrients.  Differing opinions occur over almost every issue of 
attachment.  Bacteria attach at differing rates and strengths for unexplainable 
reasons. 
Sources of Contamination 
 The main source for microbial contamination of beef products is the 
harvest floor, with the primary source being the hide (Huffman, 2002).  Dr. Dell 
Allen (2004) observed that high microbial counts on hides resulted in increased 
microbial counts on carcasses, which increased the risk of pathogen 
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contamination (Allen, 2004).  Higher fecal and ingesta contamination results in 
higher risks of having pathogenic bacteria on meat.  Facilities use several 
common indicators to determine the safety, wholesomeness and storage quality 
of meat; and they are total plate count, Enterobacteriaceae count and total fecal 
coliform count (Gorman et al., 1995;  Goepfert et al., 1975).   
 Most contamination of carcasses on the harvest floor occurs when an 
incision is made through the hide, such as sticking or opening the hide for 
removal.  Improper evisceration can result in fecal or ingesta contamination.  In 
addition to the obvious slaughter procedures, contamination can occur from the 
environment through the air, soil, water, feed, lymph nodes, improperly sanitized 
equipment, humans and carcass to carcass contamination (Ayres, 1955,1960;  
Gorman et al., 1995).  Carcasses which are contaminated at high levels (6 log 
bacteria per square centimeter) can possibly contaminate many of the following 
carcasses which are touched by equipment, personnel or the carcass (Roberts 
and Pharm, 1980).  Therefore, the level of contamination is more likely to 
increase with increased handling of the carcasses.  Charlebois et al. (1991) 
reported higher counts of microbial contamination on the forequarter of the 
animal, compared to the hindquarter; this occurrence is due to handling, carcass 
to carcass contamination or contaminated runoff water from the hindquarter of 
the carcass.  Contamination during the harvest process is unavoidable; however, 
good manufacturing practices and microbial interventions can reduce or eliminate 
microbial contamination. 
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Lactoferrin 
Background.  Sorensen and Sorensen in 1939 first reported a protein, 
lactoferrin, which was salmon pink in color containing iron from bovine milk 
(Masson et al., 1996).  However, a method to isolate the red milk protein 
described in 1939 from bovine (Groves, 1960) and human milk (Johansson, 
1960) was not refined until 1960.  Groves (1960) observed a conformational 
change took place when iron was added or subtracted from lactoferrin.  Masson 
et al. (1966) extracted lactoferrin from bronchial mucus, and reported its 
antimicrobial properties against a wide variety of micro-organisms.  Furthermore, 
Masson et al. (1966) detected lactoferrin in various mucosal surfaces and 
biological fluids, and later hypothesized the function of lactoferrin was to 
metabolize iron and serve as a natural immune defense mechanism (Farnaud 
and Evans, 2003; Naidu and Bidlack, 1998).  Since its isolation lactoferrin has 
been extensively researched by the medical society as an antimicrobial for 
natural immune defense (Locke, 2002).  Lactoferrin is derived from milk, both 
human and bovine, and is most widely used for research purposes due to its 
concentration and ease of separation.  
 When lactoferrin’s role in biological systems and its antimicrobial effects 
were defined, methods were developed to harvest lactoferrin from bovine milk.  
Lactoferrin is separated from milk whey.  Milk whey is a liquid separated during 
the manufacturing of cheese and casein, and has long been considered to be a 
major waste and disposal problem (Smithers et al., 1996).  Less than 62% of 
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world’s whey production is used, the remaining is dumped into waterways, fields 
or raw sewage.  Lactoferrin can be isolated from whey by the use of cation-
exchange column chromatography at a neutral pH.  This is easily achieved due 
to the isoelectric point (pI) of major proteins in whey being 7.0 or less, compared 
to the pI of lactoferrin being 8-9 (Law and Reiter, 1977).  Recovery of lactoferrin 
from whey ranges from 12%, to 62% depending on the method used (Smithers et 
al., 1996).  The methods of extraction of lactoferrin from whey have been refined 
to handle high volumes and obtain a purer product for numerous applications  
Lactoferrin is a fist line of defense for the body (Masson et al., 1966b; 
Naidu, 2000).  Its actual role and understanding of its specific mode of action is 
extremely controversial (Brock, 2002).  Lactoferrin’s roles include anti-
inflammatory, immunomodulator, anti-tumor, iron absorption, anti-fungal, anti-
parasitic, anti-bacterial, procoagulant, promicrobial, and auto-antibody as well as 
many more roles that are not clearly defined nor understood in the immune 
cascade of reactions (Farnaud and Evans, 2002; Naidu and Bidlack, 1998).   
Bovine derived lactoferrin was not used as an antimicrobial in meats and 
food systems until the late 1990’s (Naidu, 2000).  The Food and Drug 
Administration recognized bovine derived lactoferrin as generally recognized as 
safe (GRAS) and allowed the use as an antimicrobial on meats (USDA, 2005).  
Following approval by the FDA National Beef Packaging Company, L.P. 
(National Beef; Kansas City, Mo) began to use the spray as an intervention step 
in its multi-hurdle approach to reduce microbial loads on meats.  Furthermore, 
DMV International (Netherlands; 2005) gained approval for the use of lactoferrin 
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in sports drinks, infant formula, foods, personal care products, tablets for 
nutritional supplementation, veterinary use, animal feeds as well as meats. 
Sources and Safety.  Lactoferrin is found in most mucosal surfaces, numerous 
biological fluids as well as in blood (Masson et al., 1966).  Lactoferrin has been 
successfully detected in bronchial mucus, milk, tears, saliva, nasal secretions, 
heptic bile, pancreatic fluid, seminal fluids, cervical mucus, urine, synovial fluid, 
blood and secondary granules of neutrophils (Masson et al., 1966; Naidu, 1991; 
Yeet al. 2000; Farnaud and Evans, 2003). 
   
Table1.  Sources and Amounts of Lactoferrin Present in Biological Fluids. 
(Masson et al., 1966; Taylor et al., 2004; DMV International, 2005) 
 
Biological Fluid Amount of Lactoferrin 
Colostral Human Breast milk 7 mg/ml 
Mature Human Breast Milk 1-2 mg/ml 
Tear Fluid 2.0 – 4 mg/ml 
Seminal plasma 0.5-1.0 mg/ml 
Nasal Secretions 0.1 mg/ml 
Hepatic bile 0.01-0.04 mg/ml 
Cervical Mucus 0.5-1.0 mg/ml 
Bronchial mucus 0.001-0.01mg/ml 
Saliva 0.0007-0.01 mg/ml 
Colostral cow milk 2.0-5.0 mg/ml 
Mature Cow Milk 0.02-0.3 mg/ml 
Blood 1-200 µg/ml 
Pancreatic Fluid 0.5 mg/ml 
 
Lactoferrin is present in all mammals, but the concentration varies among 
species.  The amount of lactoferrin in milk depends on the stage of lactation 
(Sanchez et al., 1988).  Additionally, Sanchez et al. (1988) reported that 
concentrations of lactoferrin were extremely elevated in milk derived from 
mastitic cows, than milk from cows showing no symptoms of mastitis.   Moreover, 
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Masson et al. (1969) found when inflammation, disease, was present inside the 
body, blood Lactoferrin concentrations raised from 1 µg/ml to a high of 200 
µg/ml.  Most of the lactoferrin in blood was found to be from the degranulation of 
neutrophils (Taylor et al., 2004).   
    Human and bovine derived lactoferrin is the most abundant researched 
forms of lactoferrin.  Peirce et al. (1991) compared bovine and human milk 
derived lactoferrin, finding that their amino acid sequence is 69% indentical.  
Furthermore, Taylor et al. (2004) reviewed past research concluding lactoferrin 
isolated from different biological fluids were produced from the same gene.   
Therefore, Taylor et al. (2004) concluded that bovine and human derived 
lactoferrin was similar enough in structure as well as amino acid sequence, and 
should be comparable in all aspects.   
 The FDA considered lactoferrin derived from bovine milk generally 
recognized as safe as an antimicrobial spray in concentration of 2% by weight in 
2001 (US FDA, 2005).  In the response letter National Beef Packing Company, 
the FDA did not question the safety of lactoferrin derived from bovine milk, as 
long as levels did not exceed 3.26 mL of spray per kg of beef or 65.2 mg of 
lactoferrin per kilogram of beef.  The FDA and FSIS requested that National Beef 
Company, display a statement on all beef treated with lactoferrin be labeled 
“treated with lactoferrin from milk” or “treated with lactoferrin, a milk protein” (US 
FDA, 2005).  The label would fulfill the Federal Food, Drug and Cosmetic Act and 
21 CFR § 101.4, which requires that all food consisting of two or more 
ingredients, must list all ingredients the food contained (Taylor et al., 2004).  
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National Beef Company accepted the ruling issued by the FDA and FSIS used 
the labeling restriction with a supplementation as a marketing tool by adding “for 
your protection” or “for your safety” (US FDA, 2005).  To reiterate the safety of 
lactoferrin, Taylor et al. (2004) determined a 2% lactoferrin solution as a 
antimicrobial spray for beef carcasses, which does not exceed 0.20 ml per kg of 
beef carcass, there is only an insignificant increase in lactoferrin.  Taylor et al. 
(2004) deduced that National Beef Company could refuse the FDA and FSIS 
ruling of beef treated with lactoferrin.  According to 21 CFR 101.100(a)(3)(ii), 
which designates, incidental additives in food at insignificant levels, used as 
processing aids could be exempt from labeling.  Therefore, National Beef 
Company could appeal the labeling of lactoferrin as ruled by USDA FSIS (Taylor 
et al., 2004).  National Beef Company estimated a typical consumer of beef 
products consumes 4.1 mg of lactoferrin per day.  In addition, a heavy consumer 
is expected to ingest 9.1 mg of lactoferrin per day (all values for lactoferrin were 
tested in raw beef products) (US FDA, 2005).  The amount of lactoferrin found in 
beef after treatment with Activin is minimal, compared to reports that teenagers 
13 years to 19 years of age and those 20 years of age or older consume 75 mg 
per day and 50 mg per day, respectively, through the consumption of milk or 
milk-derived ingredients (US FDA, 2005).   
Locke (2002) stated that lactoferrin is a natural antimicrobial that caters to 
criteria demanded by consumers and food processors.  The following is the 
suggested criteria for preservatives and antimicrobials: (Naidu and Bidlack, 
1998). 
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  Non-toxic product that can be utilized on animals and humans 
  metabolized and excreted 
  water soluble, media of growth 
  heat stable to with stand thermal processes 
  active over a wide pH range 
Lactoferrin, derived from bovine milk, is not only safe to consume, but meets all 
requirements set forth by Locke (2002).   
Chemical and Physical Properties.  Lactoferrin is a single, chained, bi-lobed, 
glycoprotein with a molecular weight of 80 kilodaltons (Masson et al., 1969; 
Brock, 2002; Farnaud and Evans 2003).  Additionally, lactoferrin is a known 
member of the transferrin family of iron binding molecules that is present 
throughout the body (Masson et al., 1966).  The two lobes of lactoferrin are very 
similar in structure and are known as the N-terminus and C-terminus.  Each lobe 
is divided into 2 domains, which contain a single iron binding site (Anderson et 
al., 1987).  Each lobe of lactoferrin has the ability to reversibly bind one iron 
(Fe3+) molecule, accompanied with a synergistic anion with high affinity (Ka = 
1020 L/mol) (Naidu and Bidlack, 1998).  The natural anion binding molecule is 
either carbonate (CO32-) or bicarbonate (HCO3-) (Brock, 2002, Farnaud and 
Evans, 2003).  Grossman et al. (1992) observed a conformational change when 
an iron is bonded using x-ray solution scattering.  Lactoferrin’s change is 
described as a closing of the cleft where iron has been bound.  Upon the release 
of the iron atom, the cleft opens.  Lactoferrin deficient of iron is known as apo-
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lactoferrin and that which has two atoms of iron bound to it is referred to as holo-
lactoferrin ( Naidu, 2001; Farnaud and Evans, 2003).    
 Lactoferrin’s bacteriostatic properties are well documented and extend 
across a wide range of gram negative bacteria, including E. coli O157:H7, gram 
positive bacteria, viruses and fungi (Kirkpatrick et al., 1971; Arnold et al., 1977; 
Kalmar and Arnold, 1988; Yumauchi et al., 1993; Jones et al., 1994).  This ability 
to inhibit bacterial growth in vitro was first attributed as its ability to sequester 
iron, an essential bacterial nutrient for metabolism (Chapple et al., 1988), from 
the environment (Groves, 1960; Arnold et al., 1977).  Essentially lactoferrin 
starves the bacteria of this essential nutrient, causing a bacteriostatic effect 
(Naidu and Bidlack, 1998).  This ability does work in most occasions, usually in 
vitro; yet some bacteria produce siderphores to release into the environment 
when stressed (Gray-Owen and Schrivers, 1996). Siderphores are produced by 
bacteria to aid in sequestering of iron from molecules which have a greater 
affinity (Gray-Owen and Schivers, 1996).  Bacteria siderphores often have a 
higher binding affinity for iron than lactoferrin, and therefore acquire it readily 
from lactoferrin (Griffiths and Williams, 1999).  Other species of bacteria do not 
require siderphores and are able to use previously sequestered iron straight 
from lactoferrin (Herrrington and Sparling, 1985).  Unfortunately, in those 
situations lactoferrin is acting as a promicrobial molecule (Farnaud and Evans, 
2003).  Furthermore, concentration and form (apo- vs. holo-) of lactoferrin 
present can inhibit antimicrobial strength.  For example, iron saturated lactoferrin 
(holo- lactoferrin) has reduced antimicrobial activity, when the same 
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concentration is compared to iron free lactoferrin (apo- lactoferrin) (Arnold et al., 
1980, Yamauchi et al., 1993).  Lactoferrin has some antimicrobial effect by 
sequestering iron in vitro; however, in vivo iron sequestering is highly debated 
(Brock, 2002).  Brock (2002) explains that in vitro testing of lactoferrin’s 
antimicrobial activity cannot mimic the complicated interactions that can happen 
in vivo.   
 In addition to lactoferrin’s iron sequestering ability, it has demonstrated 
bactericidal properties revealed by interaction with the bacteria’s surface (Arnold 
et al., 1977, 1982; Bortner et al., 1989).  Lactoferrin has shown binding to active 
sites, and disruption or penetration of the cell membrane (Ellison and Geihl, 
1981; Yumauchi et al., 1993).  Lactoferrin specifically binds to the outer-
membrane of gram-negative bacteria causing permeability or release of the 
lipopolysaccharide membrane (Ellison et al., 1988; Apllemink et al., 1994; 
Farnaud and Evans, 2003).  Lactoferrin binds to the lipid A portion of the 
lipopolysaccharide membrane or outermembrane porins (Applemelk, 1994; 
Naidu et al., 1993).  Unfortunately, changes in pH, Mg2+ concentrations, Ca2+ 
concentrations, as well as iron saturation decrease the efficacy of lactoferrin’s 
damage to the outer-membrane of the bacteria (Botner et al., 1986, 1989; 
Kalmar and Arnold, 1988; Ellison et al., 1990; Farnaud and Evans, 2003).  In 
addition, lactoferrin’s antimicrobial ability to influence the bacteria has been 
shown to be decreased depending on the growth phase, the most susceptible is 
the early log phase.  Lastly, some believe that bacteria grown from plates are 
completely resistant (Arnold et al., 1981; Bortner et al., 1989). 
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 Lactoferrin can be hydrolyzed by pepsin resulting in a basic N-terminal 
end peptide, lactoferricin, which is more effective antimicrobial than lactoferrin 
(Saito et al., 1991; Bellamy, et al., 1992).  Lactoferricin applies positive charges 
from within the peptide to interact with the negatively charged cell membrane 
(Nikaido and Vaara, 1985) resulting in a similar effect to the outer membrane as 
described for lactoferrin.   
Table 2.  Inhibitory Spectrum of Bovine Lactoferrin (LF) and Lactoferricin (Lfcin) 
against various bacteria (Naidu, 2000a; Locke, 2002). 
Bacterial Species Form Dose Effect Reference 
Aeromonas hydrophila LF 0.1% Adhesion-blockade (47%) Paulsson et. al., 1993 
Bacillus cereus LFcin 6 µM Cidal (4-log, 100%) Hoek et. al., 1997 
Bacillus circulans LFcin 0.006% Cidal (6-log, 100%) Bellamy et. al., 1992b 
Bacillus natto IFO3009 LFcin 0.002% Cidal (6-log, 100%) Bellamy et. al., 1992b 
Bacillus stearothermophilus LF 1:20 Stasis Reiter & Oram 1967 
Bacillus subtilis LF 1:20 Stasis Reiter & Oram 1967 
Bacillus subtillis ATCC6633 LFcin 0.002% Cidal (6-log, 100%) Bellamy et. al., 1992b 
Bifidobacterium longum LF 0.1% Agglutination Tomita et. al., 1994 
Corynebacterium diphtheriae LFcin 0.018% Cidal (6-log, 100%) Bellamy et. al., 1992b 
Corynebacterium ammaniagenes LFcin 0.003% Cidal (6-log, 100%) Bellamy et. al., 1992b 
Clostridium perfringens LFcin 0.024% Cidal (6-log, 100%) Bellamy et. al., 1992b 
Clostridium paraputrificum LFcin 0.003% Cidal (6-log, 100%) Bellamy et. al., 1992b 
Enterococcus faecalis LFcin 0.06% Cidal (6-log, 100%) Bellamy et. al., 1992b 
Escherichia coli E386 LF 0.1% Stasis (24-h 100%) Naidu et. al., 1993 
Escherichia coli H10407 LF 0.1% Adhesion-blockade (50%) Paulsson et. al., 1993 
Escherichia coli IID-861 LFcin 10 µM Cidal (3-log reduction) Bellamy et. al., 1992b 
Escherichia coli CL99 LF 20 µM LPS release, OM damage Yamauchi et. al., 1993 
Escherichia coli O157:H7 LF 2% Cidal 90% Ransom and Belk, 2003
Escherichia coli O157:H7 LFcin 15.6 mg Cidal (99.9 %) Jones et. al., 1994 
Klebsiella pneumoniae LFcin 10 µM Cidal (3-log reduction) Bellamy et. al., 1992b 
Lactobacillus casei LFcin 0.01% Cidal (6-log, 100%) Bellamy et. al., 1992b 
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Bacterial Species Form Dose Effect Reference 
Listeria monocytogenes LFcin 10 µM Cidal (4-log reduction) Bellamy et. al., 1992b 
Listeria monocytogenes NCTC7073 LFcin 2 µM Cidal (4-log, 100%) Hoek et. al., 1997 
Micrococcus luteus LF 0.1% Agglutination Tomita et. al., 1994 
Proteus vulgarus JCM1668T LFcin 0.01% Cidal (6-log, 100%) Bellamy et. al., 1992b 
Pseudomonas aeruginosa IFO3446 LFcin 10 µM Cidal (4-log reduction) Bellamy et. al., 1992b 
Pseudomonas fluorescens LFcin 8 µM Cidal (4-log, 100%) Hoek et. al., 1997 
Salmonella abony  LF 0.8% Stasis (24-h 100%) Naidu & Arnold, 1994 
Salmonella Dublin LF 0.2% Stasis (24-h 100%) Naidu & Arnold, 1994 
Salmonella enteritidis LFcin 0.01% Cidal (6-log, 100%) Bellamy et. al., 1992b 
Salmonella Hartford LF 0.8% Stasis (24-h 100%) Naidu & Arnold, 1994 
Salmonella Kentucky LF 0.2% Stasis (24-h 100%) Naidu & Arnold, 1994 
Salmonella panama LF 0.1% Stasis (24-h 100%) Naidu & Arnold, 1994 
Salmonella pullorum  LF 0.2% Stasis (24-h 100%) Naidu & Arnold, 1994 
Salmonella rostock LF 0.2% Stasis (24-h 100%) Naidu & Arnold, 1994 
Salmonella salford LFcin 4 µM Cidal (4-log, 100%) Hoek et. al., 1997 
Salmonella Montevideo LF 20 µM LPS release, OM damage Yamauchi et. al., 1993 
Salmonella Thompson LF 0.1% Stasis (24-h 100%) Naidu & Arnold, 1994 
Salmonella typhimurium Rd LF 0.5% Stasis (64%) Naidu et. al., 1993 
Salmonella. Typhimurium R10 LF 0.1% Adhesion-blockade (68%) Paulsson et. al., 1993 
Salmonella. Typhimurium SL696 LF 20 µM LPS release, OM damage Yamauchi et. al., 1993 
Salmonella virchow LF 0.8% Stasis (24-h 100%) Naidu & Arnold, 1994 
Shigella flexeri LF 0.1% Adhesion-blockade (30%) Paulsson et. al., 1993 
Staphylococcus albus LF 0.5% Stasis Masson et. al., 1966 
Staphylococcus aureus LF 0.1% Adhesion-blockade (54%) Paulsson et. al., 1993 
Staphylococcus aureus JCM2151 LFcin 10 µM Cidal (3-log reduction) Bellamy et. al., 1992b 
Staphylococcus epidermidis LFcin 0.006% Cidal (6-log, 100%) Bellamy et. al., 1992b 
Staphylococcus haemolyticus LFcin 0.001% Cidal (6-log, 100%) Bellamy et. al., 1992b 
Staphylococcus hominis LFcin 0.003% Cidal (6-log, 100%) Bellamy et. al., 1992b 
Streptococcus bovis LFcin 0.006% Cidal (6-log, 100%) Bellamy et. al., 1992b 
Streptococcus lactis LFcin 0.003% Cidal (6-log, 100%) Bellamy et. al., 1992b 
Streptococcus thermophilus LFcin 0.003% Cidal (6-log, 100%) Bellamy et. al., 1992b 
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 ACTIVIN™.  Activin was developed by A. S. Naidu (Naidu, 2001).  Activin is a 
mixture of ingredients developed to be sprayed electro-statically onto meat 
surfaces to reduce microbial numbers and growth.  Activin is a mixture of 
immobilized lactoferrin, natural lactoferrin, an acid, a base and salt mixed into a 
deionized water.  
 Lactoferrin in the mixture must be derived from bovine milk, separated 
from whey.  Immobilized lactoferrin is bond to a galactose rich polysaccharide 
(Naidu, 2001).  The N-terminus region of the lactoferrin is bound to the substrate 
when iron concentrations are low.  The native lactoferrin present in the mixture is 
non-substrate bound lactoferrin, which can be either in the apo- or holo- forms.  
The mixture is preferred to contain 1% immobilized lactoferrin and 1% natural 
lactoferrin (Naidu, 2001).  The remaining buffer solution contains citric acid as the 
acid, sodium bicarbonate as the base, and sodium chloride as the salt.  The 
optimum ratio of  acid:base:salt is: 0.001M (acid): 0.01M (base): 0.1M (salt) 
(Naidu, 2001).  
 The lactoferrin and buffer solutions are then suspended in an aqueous 
solution using deionized water.  The water must meet certain specifications as 
outlined by aLF Ventures and N-Terminus Laboratory (Pamona, CA). (See 
Appendix H)  
 According to Naidu (2002) and Naidu and Bidlack (1998), Activin results in 
a microbial blocking agent which interferes with adhesion/colonization, detaches 
live or dead organisms from surfaces, inhibits microbial growth/multiplication, 
and neutralizes the activity of endotoxins.  Naidu (2002) and Naidu and Bidlack 
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(1998) claim that when Activin binds the outer-membrane of gram negative 
bacteria such as E. coli O157:H7, resulting in inhibition of cellular functions and 
deregulation of adhesion/fimbrial synthesis on the bacterial surface.  This effect 
on fimbriae of E. coli was noticed 2 hours after exposure.  Furthermore, Naidu 
(2002) hypothesized that Activin displaces bound live/dead microorganisms from 
their binding site on meat tissue causing bacterial detachment.  Activin is 
designed to produce optimum apo- to holo- regulation of lactoferrin as well as 
reduce the instance of proteolysis.  Efficacy of lactoferrin versus Activin has 
shown that Activin has greater antimicrobial effects on meat surfaces in 1% 
concentration when compared to lactoferrin in 1% concentration (Naidu, 2002).  
Therefore, Naidu (2002) reports that Activin is a microbial blocking agent that 
effectively prevents E. coli O157:H7 attaching to the surface, and inactivates it 
by binding to the cell membrane.  Ransom and Belk (2003) found that Activin in 
combination with lactic acid could prevent or suppress growth in bologna and on 
adipose tissue (~ 1 log CFU/cm2) after storage for 29 days. 
Lactic Acid 
 The most used chemical decontaminants in spray wash systems found in 
commercial processing facilities are organic acids, usually lactic or acetic acids 
(Castillo et al., 2002).  Lactic acid has been shown to effectively reduce 
pathogenic and spoilage bacteria on carcasses, sub-primals, retail cuts and trim 
for ground beef, as well as to have lasting effects on cuts in vacuum bags ( 
Hamby et al., 1987;  Dixon et al., 1987, 1991Anderson et al., 1989; Anderson et 
al., 1990; Dickson and Anderson, 1992; Ellebracht et al., 1999).  However, Acuff 
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et al. (1987) found that lactic acid had very limited antimicrobial activity on meat 
surfaces.  These inconsistencies of antimicrobial activity of lactic acid were 
clarified by Anderson and Marshall, (1990), who reported concentration and 
temperature deviations of lactic acid can reduce antimicrobial effects.  In 
addition, method of acid application, length of application, time of application 
after removal of hide, type of tissue, use of a spray chill system and bacterial 
species being tested all have an effect on the efficacy of lactic acid (Sirugusa and 
Dickson, 1992; Dickson, 1991; Anderson et al., 1992).   
 The use of lactic acid is currently approved at concentrations of 1.5- 2.5% 
(USDA FSIS, 1996).  The maximum effectiveness of lactic acid is achieved 
shortly following hide removal, while the carcass is still warm (Huffman, 2002).  
Nonetheless, studies have shown that 4% lactic acid is also effective in 
controlling pathogens on chilled beef carcasses (55°C) (Castillo et al., 2001).  
Lactic acid is considered to be most effective if applied at a temperature of 55° C 
or higher as a rinse.  Rinses of varying concentrations (0.5% to 5%) resulted in 
reductions from 1 to 4 log10 CFU/cm2, with variation due to factors previously 
stated (Greer et al., 1992).  Currently, lactic acid rinses are suggested and used 
pre- and post-evisceration to maximize it effect on bacteria (Cutter and Siragusa, 
1994; Dorsa et al., 1997, 1998; Delmore et al., 1998; Huffman, 2002). 
Chemical and Physical Properties.  Lactic Acid is naturally found in animal 
tissues, which increases during the conversion of muscle to meat (Baird Parker, 
1980; Romans et al., 1994).  Lactic acid (CH3CHOHCOOH), a short chain 
organic acid, is highly soluble in water with a pKa of 3.1.  Lactic acid is a stronger 
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decontaminate than acetic acid (CH3COOH), being attributed to the longer chain 
length; Organic acid with longer chain lengths have stronger antimicrobial 
properties (Baird Parker, 1980).   
Antimicrobial activity is attributed to the undissociated molecule of the 
organic acid (Ingram et al., 1956).  The accumulation of the undissociated weak 
acids in the cytoplasm of the cell is due to the intracellular pH being higher than 
the pKa of the acid resulting in the dissociation of the acid releasing a proton and 
acidifying the microorganism’s cytoplasm (Booth, 1985; Huffman, 2002).  When 
organic acid is used in concentrations greater than 1%, Baird Parker (1980) 
reports they are very effective antimicrobials against a wide variety of 
microorganisms.   
Hot Water Spray Washing 
 Exposure of animal tissues to hot water by various methods of application 
is effective in controlling many spoilage as well as pathogenic bacteria (Barkate 
et al., 1993;  Smith, 1992;  Davey and Smith, 1989;  Smith and Graham, 1978; 
Patterson, 1969).  USDA-FSIS (1996) acknowledged hot water washes, having 
temperatures in excess of 74°C, produced a sanitizing effect and are approved 
as a valid step in HACCP to control pathogens.  Previous work demonstrates that 
hot water rinses reduce bacterial counts from 1-3 log CFU/cm2 (Acuff et al., 1996;  
Gorman et al., 1995;  Barkate et al., 1996;  Kelly et al., 1981).  Paterson (1969) 
first reported a reduction in bacterial numbers with the use of a hot water steam 
mixture (80-96° C) for 2 minutes delivering 18.9 liters of water to the samples 
surface.  Smith and Graham (1978) found a reduction of two to three logs of E. 
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coli and Salmonella when beef and sheep surface tissue samples were 
immersed in hot water.  Smith (1992) reported a reduction of pathogenic E. coli 
when inoculated on beef brisket tissue and treated with water (80°C) for 10 and 
20 seconds.  Gorman et al. (1995) and Kochevar et al. (1997) observed a 
reduction similar to that of Smith (1992) using a simulated spray-wash unit with 
water (74°C).  In addition, this treatment showed an improvement in visual 
appearance, removing fecal and other contamination, required by the ‘zero 
tolerance’ policy in place by the USDA.  Reagan et al. (1996) observed that 
trimming carcasses at line speed removed visual contamination, but hot water 
washing (74°-87.8° C, 11-18 seconds, 1310-2413 kPa) was better to remove 
microorganisms.  The hot water wash was able to reduce bacterial numbers by 
injury and death due to elevated temperatures present in the study.  However, 
consideration must be given that washing may potentially spread contamination 
from one area of a carcass to another (Barkate et al., 1993).  Gorman et al. 
(1995) reported no potential spreading of microbial contamination using a pilot 
scale spray-washing unit.  Despite this other problems have arose in the 
widespread application in commercial facilities such as amount of water needed, 
energy needed, spray nozzle problems, and condensation formation problems in 
and around the cabinets (Reagan et al., 1996).  Also, problems with water 
loosing temperature and application flaws have increased the concern for use in 
the industry.  Finally, the effectiveness of the hot water wash is dependent on 
temperature, exposure time, pressure, design of the cabinet and facilities.   
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High Pressure Water Washing 
 The use of high pressure spray-washing has been typically used to reduce 
visible contamination, microbial contamination and bone dust after splitting the 
carcass.  A concern in the use of high pressures has been the possibility of 
physically driving the contamination into the muscle and adipose tissue (Gorman 
et al., 1995) and spreading contamination from one area of a carcass to another 
(Barkate et al., 1993).  DeZuninga et al. (1991) recommends that the maximum 
pressure for use in a spray-washing cabinet to be 2070 kPa, based on their dye 
penetration model;  the limit is suggested to decrease the possibility of physically 
driving bacteria into muscle and adipose tissue.  Reagan et al. (1996) reported 
less E. coli O157:H7 positives were found on carcasses that were washed (28°-
42° C, 410-2758 kPa, 18-39 seconds) compared to carcasses that have been 
trimmed or trimmed and then washed.  Effectiveness of bacteria reduction is 
dependent on water pressure, angle of nozzles, time of exposure to treatment, 
and water temperature.   
Other Harvest Microbial Interventions 
Hide on Carcass Washing.  Cargill Meat Solutions has recently spent millions of 
dollars on the instillation of a hide on carcass wash system to reduce initial 
bacterial numbers entering the facility (Allen, 2004).  Reducing the number of 
bacteria from the major source of potential contamination, the hide, will reduce 
the microbial contamination of carcasses upon entering the hot box (Allen et al., 
2004).  Bosilevac et al. (2005) found that hides, when sampled before entering 
    29 
and after exiting the cabinet, had lower aerobic plate counts and 
Enterobacteriaceae counts, being reduced by 2.1 and 3.4 log CFU per 100 cm2, 
respectively.  The prevalence of E. coli O157 on hides was reduced from 44% to 
17% of hides when the cabinet was in use. Pre-evisceration carcass aerobic 
plate counts and Enterobacteriaceae counts were both reduced by 0.8 log CFU 
per 100 cm2, and the prevalence of E. coli O157 was reduced from 17% to 2% 
when the cabinet was in use.  The hide on carcass wash system uses a sodium 
hydroxide wash, followed by a chlorinated (1 ppm) water rinse and the use of a 
steam vacuum system to remove excess water from the pattern where the hide 
will be opened. The use of the additional steam vacuum increased the reduction 
of bacteria beyond carcass wash alone.   
Chemical Dehairing.  The dehairing process described and used in testing of 
the process consists of 3 steps considered to be bacteriostatic and/or bactericidal 
are: application of sodium sulfide, hydrogen peroxide and rinsing with lactic acid 
(Bowling and Clayton, 1992; Sofos and Smith 1998).  Schnell et al. (1995) 
reported no reduction in aerobic plate counts.  However, Catillo et al. (1998) and 
Graves-Delmore et al. (1997) reported reductions in pathogenic bacteria on the 
beef hides after being dehaired by the three chemical processes.  Despite these 
findings, chemical dehairing is costly and slows chain speeds. 
Steam Pasteurization  According to Dr. Allen steam pasteurization is the most 
critical microbial intervention in Cargill Meat Solutions harvest process, stating “if 
it is down, we do not operate”.  He goes on to comment that “all other 
interventions are just band aids in the slaughter process,” (Meat News, 2003).  
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Steam pasteurization is another means to obtain thermal destruction of bacteria 
on the surface of carcasses.  The process begins with a drying process to 
remove any excess moisture from the carcass, followed by steam (≥83° C) 
treatment from 10-20 seconds, and followed by a cooling process.  Reductions of 
bacteria are comparable to hot water rinse resulting in a 2-3 log CFU/cm2 
reduction (Gill et al., 1999).  Steam pasteurization is more efficient than hot water 
and less likely to spread contamination, because of the “wrap around” effect of 
the steam.  Currently, the larger beef packers in the United States and Oklahoma 
State University use steam pasteurization as one of their main critical control 
points.   
Steam Vacuum  The use of steam vacuuming of small areas of contamination is 
a widely accepted practice in the beef packing industry.  Steam vacuuming uses 
steam and/or hot water to loosen soil and kill bacteria, followed by application of 
a vacuum to remove contaminants (Castillo et al., 1999; Dorsa et al., 1996; 
Kochevar et al., 1997; Sofos et al., 1999).  Most steam vacuuming occurs after 
hide removal and follows the pattern where the hide is initially opened.  Castillo 
et al. (1999) found that steam vacuuming reduced the number of indicator 
organisms 3 log cycles; unfortunately, vacuuming tended to spread 
contamination to adjacent sites.  FSIS approved the use of steam vacuuming a 
contaminated area of up to 2.5 cm in diameter.   
Multi-Hurdle Approach 
 Leistner (1995) describes the “hurdle approach’ as sequential use of 
decontamination technologies.  The multi-hurdle approach simply implies that if a 
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single application of a single decontamination treatment achieves a certain 
reduction of microbes, then the use of two, three or more different treatment 
technologies, will yield a synergistic effect when combined.  Bacon et al. (2000) 
observed aerobic plate counts, E. coli counts and total coliforms gradually 
reduced through out the stages of slaughter process after decontamination steps 
were applied.  The eight commercial facilities used a number interventions 
including steam vacuuming, pre-evisceration washes (water and organic acid), 
hot water, post-evisceration washes and steam pasteurization.  Elder et al. 
(2000), also reported similar results where 43.4% of the lots evaluated were 
positive for E. coli O157:H7, however after all interventions were applied only 
1.9% were positive.  Despite the so called additive effect, Dr. Keith Belk in an 
interview stated “Multi-hurdle systems can become overwhelmed and could not 
handle the load of E. coli O157:H7” (Ishmeal, 2003).  Hurdle technology has 
shown an additive effect, however the systems that we have in place have a 
thresh hold and cannot always decrease the levels to zero (Meat News, 2003).  
Cargill Meat Solutions has implemented a carcass wash system to their 
approach to help reduce the load to a number in which their hurdle approach can 
effectively handle (Allen, 2004).  Furthermore, in the last few years research to 
eliminate or reduce pathogenic bacteria from cattle before entering the harvest 
floor has increased.   
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CHAPTER III
EFFICACY OF ELECTROSTATICALLY SPRAYED ACTIVIN™ (ACTIVATED  
LACTOFERRIN), HOT WATER, HIGH PRESSURE WATER, AND LACTIC  
ACID INDIVIDUALLY AND USED IN A MULTI-HURDLE APPROACH TO  
REMOVE ESCHERICHIA COLI O157:H7 FROM BEEF TISSUES 
 
A. W. TITTOR, J. B. MORGAN, C. A. MIRELES DEWITT, J. R. ESCOUBAS,   
J. NELSON, P. MURIANA 
 
OKLAHOMA STATE UNIVERSITY, STILLWATER, OK 74078 
 
ABSTRACT 
Validation of electrostatically sprayed Activin as a microbial intervention was 
investigated through 3 experiments:  Experiment 1) Comparison of Activin (A), 
hot water rinse (HW), 2% lactic acid (LA) spray, Activin Buffer solution (B), high 
pressure water rinse 3s 15s (HP3) and high pressure water rinse 15 s (HP15) to 
reduce E. coli O157:H7 on inoculated (6 log CFU/cm2) adipose tissue.  Greater 
(P< 0.05) reduction of E. coli O157:H7 was shown for adipose tissue samples 
treated with HW than HP3, B, HP15 and A.  No differences (P> 0.05) were 
evident between treatments of LA, HP3, HP15, and A on E. coli O157:H7.  
Experiment 2) Evaluation of National Beef Packing Company’s multi-hurdle 
intervention sequence with Activin (MH-A) and without Activin (MH-NA) on E. coli 
O157:H7 (6 log CFU/cm2) on adipose and lean tissue.  No difference (P> 0.05) in 
reduction of E. coli O157:H7 was found on samples treated with MH-A and MH-
NA on lean or adipose tissue, 2.4-2.9 log CFU/cm2.  Experiment 3) Reduction of 
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total plate counts (TPC), Coliforms, Enterobacteriaceae (ENT), and lactic acid 
bacteria (LAB) on uninoculated lean and adipose tissue treated with MH-A and 
MH-NA and stored for 7 days (7° C).  Adipose tissue treated with MH-A displayed 
reduced (P< 0.05) coliform counts following 7 d storage than adipose tissue 
treated with MH-NA.  Lean samples treated with MH-A or MH-NA had significant 
(P< 0.05) higher reductions of TPC and LAB than adipose tissue treated with 
MH-A and MH-NA.  No differences were observed for ENT for tissues or 
treatments.  Greater reductions (P< 0.05) for LAB were observed on lean 
samples treated with MH-A than MH-NA following storage.  In summary, Activin 
used either in a single treatment or a multi-hurdle approach was not significantly 
more effective than any other treatment against E. coli O157:H7.  However, 
Activin did show an effect on coliforms and LAB following a 7 day storage period.   
Key Words: Activin, lactoferrin, decontaminates, beef, E. coli O157:H7 
 
INTRODUCTION 
E. coli O157:H7 is the major food safety concern for the beef industry, and 
has cost the industry over $2.6 billion in the past 10 years (NCBA, 2005).  Since 
1982, there have been over one hundred outbreaks of E. coli, of which 52% were 
linked to beef (Elder et al., 2000, Arthur et al., 2004).  In 2005, the FSIS reported 
a 43.3% decrease in E. coli O157:H7 positives in ground beef from 2003 to 2004 
and an 80% decrease in positives since 2000 (NCBA, 2005c).  This reduction is 
due to the industry’s implementation of HACCP and carcass washes/sanitizing 
practices including steam pasteurization, hot water washes (>74° C), organic 
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acid rinses, steam/hot water vacuum, and high pressure water rinses (NCBA, 
2005c)  
In 2001, A. S. Naidu developed and patented a new organic microbial 
blocking agent, Activin.  Activin’s main ingredient, lactoferrin derived from bovine 
milk whey, is proven to be bacteriostatic and bactericidal against many gram-
negative and gram positive bacteria (Farnaurd and Evans, 2003).  Lactoferrin 
has the ability to sequester iron, attach to the bacterial cell’s membrane causing 
damage and/or death, detach bacteria from the surface of beef tissue, and attach 
to the surface of beef tissue blocking bacteria attachment sites (Naidu and 
Bidlack, 1998).  Locke (2002) observed MAP beef steaks treated with Activin 
suppressed total plate counts and extended desirable color by two days.   
 The objectives of this research was to compare Activin treatments to other 
proven interventions (i.e. hot water, high pressure, lactic acid) on the reduction of 
E. coli O157:H7 on adipose tissue, evaluate Activin’s ability used in a multi-
hurdle spray wash sanitizing sequence to enhance reduction of E. coli O157:H7 
on lean and adipose tissues, and evaluate Activin’s ability used in a multi-hurdle 
sequence to reduce natural bacterial loads on lean and adipose tissue following 
a 7d refrigerated storage period.  The multi-hurdle sequence was National Beef 
Packing Company’s.  All times, temperatures, treatments, and chain speeds 
simulated actual commercial processing. 
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MATERIALS AND METHODS 
Description of Model Spray Cabinets 
Test Wash & Sanitizing Spray Cabinet.  A model spray washing and 
sanitization cabinet was designed by Chad Co. (Olathe, KS), (See Figure 2).  
The cabinet had two chambers with the ability to spray three different liquids at 
any one time.  The cabinet included a mechanized plate (20 cm x 20 cm) to 
suspend samples during treatment and was able to simulate chain speeds.  
Samples were suspended 30.5 cm from all spray nozzles.  The first chamber was 
capable of supplying sanitizing chemical agents in a fine mist through four 
nozzles (H1/8VVSS80015; UniJet, Wheaton, Illinois).  The nozzle pattern created 
a vertical spread of solution to cover the sample while in motion.  The second 
chamber contained the remaining two spraying apparatus for application of spray 
treatments.  A set stationary pattern of 2 nozzles (H1/8USS5020; UniJet) for low 
pressures created a vertical fan pattern that completely covered the sample plate 
area.  These nozzles where placed one above the other.  The second had 6 
oscillating (64 revolutions per minute) nozzles (1/8MEG2510; UniJet) for higher 
pressures (758-2500 kPa) with horizontal spray patterns.  The nozzles were 
stationed 3 sets of 2 on top of each other.  Each nozzle during rotation sprayed 
water from the top of the cabinet to the bottom covering the sample plate.  The 
cabinet was self contained and all runoff from various treatments was captured in 
a tank and sanitized with a predetermined amount of sodium hypochlorite to kill 
any pathogenic bacteria.  During application of heavy spray treatments in 
chamber two, the cabinet was fully closed with doors on both ends to prevent the 
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spread of any pathogenic bacteria.  For additional nozzle information see tables 
in Appendix F.  
Electrostatic Spray System (ESS).  A model electrostatic spray system and 
cabinet was designed to replicate National Beef Packing Company’s system 
currently in use by Electrostatic Spraying Systems (Watkinsville, GA).  The 
system was comprised of a plastic cabinet (Figure 8), a 2 dimensional aluminum 
carcass (238.7 cm x 72.66 cm) for sample suspension, a four nozzle electrostatic 
module assembly (using 3 of the nozzles) and an Alan-Bradley Control Module.  
The system was designed to allow 3 milliliters of solution to be dispersed per 
nozzle (n=3), at an air flow rate of 0.218 standard cubic meters per minute, with a 
droplet charge of 20 µ Amperes to 8 µ Amperes.  The sample was suspended in 
the middle of the grounded aluminum carcass with hooks and faced directly at 
the nozzles approximately 91.5 cm from nozzle to sample.  
Inoculum preparation 
 A six strain inoculum of Escheria coli O157:H7 was prepared from five 
viable strains (237AC1, 299AB3, 133AC1, 114AC1 and 55AC1) obtained from 
United States Department of Agriculture (USDA) Meat Animal Research Center 
(Clay Center, Nebraska).  A sixth E. coli O157:H7 strain (ATCC 43895) was 
obtained from the American Type Culture Collection (Manassas, VA).  Each 
strain was prepared in a tryptic soy broth (TSB), and grown overnight at 37° C.  A 
portion of each culture was combined, vortexed, and diluted (1 x 108 cfu/ml) 
immediately prior to use.  Following preparation of the six strain inoculum, it was 
placed into coolers with ice packs, and immediately transported to the abattoir of 
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Oklahoma State University Food and Agriculture Products Center (FAPC) 
(Stillwater, OK), a USDA inspected facility, for inoculation of samples. 
Sanitizing treatments 
 The sanitizing treatments consisted of Activin, Activin’s buffer, 2 % lactic 
acid, high pressure water and hot water.  Activin and buffer solutions (aLF 
Ventures LLC, Pomona, CA; Naidu, 2001) were prepared by mixing de-ionized 
water meeting specifications set forth by aLF Ventures LLC, 24 h prior to use and 
held in closed containers at 7° C until use.  Activin and buffer were applied at 7° 
C and each sample received 9 ml of spray (3 ml from 3 nozzles) from the ESS for 
all experiments.  A 2% lactic acid solution (88 % stock solution, Birko 
Corporation, Henderson, CO) was diluted using purified bottled water 24 hrs prior 
to using the liquid.  Lactic acid was held and applied at room temperature (24° C- 
28° C).  To simulate chain speed application (270-300 carcasses per hour) at a 
distance of 15.24 cm per second, a flow rate of 0.416 liters per minute at a 
pressure of 137.9 kPa per nozzle.  The high pressure water wash was applied as 
samples were stationary, using tap water at 32° C and a pressure of 758.4 kPa 
rinsing dispensing 7.04 liters per minute.  Lastly, the hot water wash used a 
mixture of tap water and steam (93.3° C upon entering the cabinet) to achieve a 
meat surface temperature of 71° C, verified by a temperature recording decal 
(Wahl Instruments Inc., Asheville, NC).  The hot water rinse dispensed 3.13 liters 
per minute at 34.47 kPa.   
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Sample Handling  
 Hot (25° C to 30° C) adipose tissue, removed from the area covering the 
deep pectoral (brisket), and/or hot lean tissue (25° C to 30° C), Cutaneous omo-
brachialis (shoulder rose), were removed from carcasses following hide removal, 
but prior to application of any post-mortem antimicrobial washes from a 
commercial slaughtering facility (Creekstone Farms, Arkansas City, KS).  The 
tissue samples were transported to FAPC using unsealed vacuum bags 
(Cryovac, Duncan, SC) in a ice chest to maintain temperature (25° C to 30° C), 
until inoculation (< 3 hrs).  Each sample was placed horizontally on chemically 
sterilized metal trays, aseptically cut with a sterile knife blade into approximately 
15 cm x 10 cm rectangular portion, four 25 cm2 areas were marked with sterile 
stainless steel templates (5 cm x 5 cm, 25 cm2) using edible ink, and inoculation 
was accomplished by evenly dispensing 0.25 mL over the 25 cm2 area, to 
accomplish an inoculation of 1 x 106 CFU/cm2.  The inoculum was then carefully 
spread not to allow run off outside of the marked area.  Following inoculation 
each sample was assigned a treatment and held at room temperature (25° C to 
28° C) for 30 min to allow for attachment of bacteria.  Two 25 cm2 areas were 
aseptically removed for pre-treatment (control) enumeration using a sterile knife 
and forceps.  The remaining two 25 cm2 areas were then spray-washed with 
specified treatments under specific conditions.  Following specified treatments, 
the remaining two 25 cm2 samples were aseptically removed for post-treatment 
enumeration using a sterile knife and forceps.  All samples were aerobically 
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packaged in a Whirl-Pak bag, sealed and placed on ice for overnight shipment to 
Food Safety Net Services (San Antonio, TX). 
Description of Experiments. 
Validation Experiment.  A validation attachment experiment was carried out to 
determine the effect length of time between hide removal and sample inoculation 
has on attachment of E. coli O157:H7.  Adipose tissue was removed from beef 
carcasses (as described earlier) at the FAPC abattoir, placed in bags to simulate 
transport, and carried to the FAPC pathogen lab (room 307).  Samples (n=25) 
were then inoculated after 60, 90, 120 150, 180 min as described below.  After 
inoculation, there was an attachment period of 30 min.  Samples (25 cm2) were 
excised as described and placed in a Whirl-Pak bag, with 25 ml of buffered 
peptone water.  Samples were pummeled using a Seward Laboratory 
Stomacher/Blender 400 (Seward Company, United Kingdom) at low speed for 5 
s to remove loosely attached cells.  Samples were removed, placed in sterile 
Whirl-Pak bag, and enumerated at FAPC pathogen lab using the same 
procedure as below. 
Experiment 1.  This experiment evaluated all treatments using adipose tissue. 
Treatment 1: Activin (A) application by electrostatic spray, wait for 30 
min followed by a high pressure water rinse for 15s. 
Treatment 2: Activin buffer (B) application by electrostatic spray, wait for 
30 min followed by a high pressure water rinse  for 15s. 
Treatment 3: Lactic Acid rinse (LA) for 15.24cm/s , wait for 30 min 
followed by a high pressure water rinse  for 15s. 
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Treatment 4: Hot water rinse (HW) for 3 s, wait for 30 min followed by a 
high pressure water rinse  for 15s. 
Treatment 5: High pressure water rinse (HP3) for 3 s, wait for 30 min 
followed by a high pressure water rinse for 15 s. 
Treatment 6: Single high pressure water (HP15) rinse for 15 s. 
Experiment 2 (National Beef Company Multi-Hurdle Sequence).  Experiment 
2 evaluated the National Beef Packing Company’s multi-hurdle sequence with 
Activin (MH-A) and without Activin (MH-NA) on lean and adipose tissue.  
Information of the National Beef Company multi-hurdle sequence is overviewed 
in Figure 4.  
Figure 4: National Beef Company intervention sequence with Activin (MH-A) 
and without Activin (MH-NA). 
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Experiment 3 (Shelf-life).  The objective was to evaluate differences of natural 
microbial loads (uninoculated) on adipose and lean tissue treated with MH-A and 
MH-NA after 7 days stored at 7° C.  All the samples were removed aseptically as 
described above and placed in a Whirl- pak bag and stored (7°C) for 7 days and 
shipped to Food Safety Net Services for enumeration of total plate counts, 
coliform counts, Enterobacteriaceae, and Lactic Acid Bacterial counts. 
Microbial Enumeration  
E. coli O157:H7.  25 ml of buffered peptone water to the bags containing the 25 
cm2 samples.  The bags were pummeled using a Seward Laboratory 
Stomacher/Blender 400 (Seward Company, United Kingdom) for 1 minute at 230 
RPM, diluted when necessary and 1 ml of diluent was plated in duplicate onto 
ntRainbow plates.  The plates were incubated (37° C) for 24 hrs and counted.  
This method allowed for a limit of detection down to 1 cfu/ cm2.  (AOAC, 2000) 
Total Plate Count.  Food Safety Net Services followed standard plating 
methodology as outlined by FDA’s Bacteriological Analytical Method (US-FDA, 
2005).  Samples were diluted with peptone in a sterile stomacher bag and 
stomached for 1 minute.  The homogenate was then spiral plated (0.25 ml per 
plate in quadruplet) onto tryptic soy agar.  Plates were incubated at 25° C for 48 
hrs, counted and reported in CFU per cm2. 
Coliform Count.  Coliforms were enumerated using 3M Petrifilm Coliform Count 
Plates (St. Paul, MN) (3M, 2005a).  Samples were diluted with peptone in a 
sterile stomacher bag and stomached for 1 minute.  The homogenate was then 
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plated in quadruplet.  The films then were incubated at 32° C for 24 hrs, counted 
and reported in CFU per cm2. 
Enterobacteriaceae.  Enterobacteriaceae were enumerated using 3M Petrifilm 
Enterobacteriaceae Count Plates (St. Paul, MN) (3M, 2005b).  Samples were 
diluted with peptone in a sterile stomacher bag and stomached for 1 minute.  The 
homogenate was plated in quadruplet.  The films then were incubated at 35° C 
for 24 hrs, counted and reported in CFU per cm2. 
Lactic Acid Bacteria.  Food Safety Net Services used a standard method for 
enumeration of lactic acid bacteria from Compendium for the Microbiological 
Examination of the Foods (1992) 
Data Analysis 
 Data in the form of colony forming units per cm2 were analyzed using Proc 
Mixed method (PROC mixed Version 8, SAS Institute, Cary, NC) to analyze 
attachment of E. coli O157:H7 over time on adipose tissue (Validation 
Experiment), compare reductions of E. coli O157:H7 by the first treatment 
(Experiment 1), reduction of E. coli O157:H7 due to different sequential spray 
treatments (Experiment 2) and the reduction of bacteria detected at the end of 
the storage period (Experiment 3).  Reductions for each treatment were 
determined by first averaging amount of bacteria in CFU/cm2 on the controls for 
each individual sample (n=2), minus the treated samples (n=2).  A predetermined 
significance level of P< 0.05 was used.  Mean separation was completed using 
Least Significance Difference.  
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RESULTS 
Validation Experiment (E. coli 0157:H7 Attachment).  The amount of tightly 
bound bacteria on fat samples decreased as time between hide removal and 
inoculation increased (P< 0.05) (See Figure 5).  Greatest attachment, 5.24 log 
CFU/cm2, occurred at only 60 min following hide removal, having significantly (P< 
0.05) greater attachment of E. coli O157:H7 on adipose tissue, than inoculated 
120, 150 and 180 min following hide removal.  Furthermore, samples inoculated 
90 min following hide removal were significantly different (P< 0.05) than those 
inoculated 180 min following hide removal, having attachment of E. coli O157:H7 
of 5.07 log CFU/cm2 and 4.79 CFU/cm2, respectively.  There was no difference 
(P> 0.05) in attachment of E. coli O157:H7 on samples inoculated 90 min 
following hide removal to samples inoculated 120 and 150 min following hide 
removal.  All samples inoculated at 120, 150 and 180 min, displayed no 
difference (P> 0.05) in attachment of E. coli O157:H7 on adipose tissue.   
Experiment 1.  All spray-washing/rinsing treatments effectively reduced the 
amount of E. coli O157:H7 on adipose tissue between 1.6-2.8 log CFU/cm2 
(Table 3 & Figure 6).  The treatment-by-day interaction was not significant (P> 
0.05) of the single treatments.  However, significant main effect differences (P< 
0.05) were observed for the reduction of E. coli O157:H7 across the two days of 
sampling, with the samples that were subjected to treatments on d 1 having 
higher (P< 0.05) reductions of E. coli O157:H7 than that of samples being 
subjected to treatments on d 2 of sampling, 2.6 log CFU/cm2 vs. 2.1 log CFU/cm2 
respectively.  All samples subjected to the six treatments on d 1 responded 
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similarly, having no significant difference (P> 0.05).  However, d 2 of sampling 
revealed differences (P< 0.05) in reductions of E. coli O157:H7 across means of 
the six treatments.  Samples subjected to HW had the highest average reduction 
of E. coli O157:H7, 2.8 logs CFU/cm2, being significantly greater (P< 0.05) than 
samples subjected to treatments of HP15, A, HP3 and B.  No reduction 
differences (P> 0.05) of E. coli O157:H7 were observed between samples 
receiving HW and LA treatments.  Furthermore, LA treatments displayed larger 
reductions (P< 0.05) of E. coli O157:H7 than samples treated with B.  Samples 
treated with A, B, HP3 and HP15 displayed no differences (P> 0.05) in reduction 
of E. coli O157:H7 on adipose tissue.   
Experiment 2 (National Beef Multi-Hurdle Sequences).  Both intervention 
sequences (MH-A, MH-NA) were effective in reducing E. coli O157 from both 
adipose and lean tissues, 2.6-2.8 log CFU/cm2.  No differences (P> 0.05) were 
observed for the tissue-by-treatment interaction.  Additionally, neither treatment 
nor tissue main effects were found be significant (P> 0.05) as well.  (Figure 7)   
Experiment 3 (Shelf-life).  The uninoculated/unwashed controls on both lean 
and adipose tissue reached total plate counts (TPC) in excess of 6 logs 
CFU/cm2, following a 7 d storage period (7° C).  As for TPC, there was no (P> 
0.05) treatment-by- tissue interaction, nor was there a difference (P> 0.05) in 
suppression of growth due to treatment of both adipose and lean samples MH-A 
or MH-NA. (See Figure 8)  However, both sequential spray treatments applied to 
lean tissue displayed a much greater (P> 0.05) reduction, 2.7 log CFU/cm2, on 
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TPCs than did the treatments applied to adipose tissue, having a suppression of 
growth of 0.37 CFU/cm2.   
 There was no (P> 0.05) treatment-by-tissue sample interaction on 
reduction of coliforms.  Furthermore, there was no (P> 0.05) difference for the 
main effect of tissue type.  Nonetheless, uninoculated adipose samples treated 
with MH-A significantly (P< 0.05) suppressed the growth of coliforms, when 
compared to adipose tissue treated with MH-NA following the storage period 
(See Figure 9). 
 There was no differences (P> 0.05) observed in the reduction of 
Enterobacteriaceae on tissue sample or treatment type.  There was a slight trend 
(P=0.15) showing  both lean and adipose tissue samples treated with MH-A 
suppressed Enterobacteriaceae counts over both lean and adipose tissue 
samples treated with MH-NA, having a reduction of 2.12 CFU/cm2 and 1.16 
CFU/cm2 over control samples, respectively (Figure 10).   
 No treatment-by-tissue interaction was observed (P> 0.05) for the 
reduction of lactic acid bacteria.  However, lean samples treated with MH-A and 
MH-NA had significantly (P< 0.05) decreased growth of lactic acid bacteria 
following storage, when compared to adipose samples treated with MH-A and 
MH-NA following storage.  In addition, lean samples treated with MH-A had an 
extremely higher (P< 0.05) reduction of lactic acid bacteria, than lean samples 
treated with MH-NA.  Lastly, there was no difference (P> 0.05) in the suppression 
of lactic acid bacteria due to treatment on adipose tissue following a storage 
period. (See Figure 11). 
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DISCUSSION 
The validation experiment proved there was differences (P< 0.05) 
between 60 min following hide removal and 180 min following hide removal to 
inoculation for the attachment of E. coli O157:H7; however, sample collection (25 
min) and transportation (75 min) would cause inoculation of samples to be after 
90 min post-hide removal.  Statistical analysis revealed that 120 min, 150min and 
180 min post-hide removal inoculation times were not different (P> 0.05) in 
attachment of E. coli O157:H7.  Thus, the point in which we would stop 
inoculating would be 180 min.  In addition, to reduce the variation from the 
sample that was inoculated at the beginning until the last sample, treatments 
where randomly pre-determined to reduce the variation in the number of 
organisms that would attach.  This difference might be due to the noticeable 
change in appearance of adipose tissue as time after hide removal increased.  
The adipose tissue appeared dry and plastic like, which was thought to be 
caused by the loss of moisture.  The inoculum seemed to take longer to absorb 
onto adipose tissue as length of post-hide removal to inoculum increased.  
According to Firstenberg-Eden (1981), attachment of bacteria happens in a two 
stage process, a loose reversible stage and an irreversible stage.  If the inoculum 
took longer to absorb, the bacteria did not reach the surface at the same time, 
and the second stage of attachment of some bacteria may either not have 
occurred or be weak enough that the quick (5 s) pummeling released these 
bacteria.  Background bacteria present on the adipose tissue may have also 
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played a small role in the number of E. coli O157:H7 attached as time increased 
from hide removal. 
 On the first day of Experiment 1, an unexplained amount of condensation 
and iron was found in the filtered high pressure air line used for A and B 
applications.  The problem was eliminated by installing a drier/filter into the line 
prior to the air entering the electrostatic spray system.  This was accomplished 
before any testing was done on the second day.  There is an unexplained 
significant (P< 0.05) main effect, that occurred in which the first day not only had 
greater reductions (P< 0.05), but data shown in table 7 revealed there is a much 
a higher and consistent number of bacteria found on the first day’s control 
samples, 5.2-6.1 log CFU/cm2, than the controls on the second day, 4.4-5.3 log 
CFU/cm2.  However, the treated samples show similar levels on d 1 and d 2, 
having 2.4-3.0 log CFU/cm2 and 1.6 -2.8 log CFU/cm2, respectively.  Bacterial 
attachment to animal tissues is complex (Firstenberg-Eden, 1981). The 
attachment of bacteria on the control samples could be affected by inoculum 
concentration (Butler et al., 1979;  Notermans and Kampelmacher, 1975), 
temperature of the medium used for attachment (Butler et al., 1979), structure 
and morphology (Butler et al., 1979), the individual inoculating, or individual 
enumerating the samples.  In Experiment 2 (National Beef Company sequence),  
bacterial attachment differences between adipose tissue and lean tissue was not 
statistically significant , which is in agreement with findings by Cabedo et al. 
(1997) and Dickson and Frank (1993).  The reductions between adipose tissue 
and lean tissue in Experiment 2 were not significantly different (P> 0.05).  
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However, Dickson (1998) suggested a stronger attachment occurs on muscle 
tissue than adipose tissue when washed with NaOH and KOH.  Dickson and 
Frank (1993) reported an unexplained high variability in irreversible attachment of 
cells attached to adipose tissue.  Thus our findings demonstrate there is no 
difference in attachment or strength of irreversible attachment of E. coli O157:H7 
to adipose or lean tissues for experiment 2.   
The results obtained in experiment 1 for HW for overall reduction of E. coli 
O157:H7 having 2.8-3.0 log CFU/cm2, is similar to the reductions reported by 
Gorman et al. (1995).  Working with an inoculation fecal cocktail containing E. 
coli, they found that when the first spray washing treatment involved used hot 
water (74° C), reductions in counts achieved were in excess of 3.0 log CFU/cm2.  
Additional treatments did not further reduce E. coli O157:H7.  The authors 
suggested chemical interventions would not be necessary if hot water (74° C; 
pressures 276, 689, or 2068 kPa) was the intervention chosen for carcass 
decontamination (Gorman et al., 1995).   
LA was as effective as HP15 rinse alone at reducing E. coli O157:H7 
adipose tissue (P<0.05).  Thus, LA could possibly take longer than the time 
allotted to affect E. coli O157:H7.  LA has been shown to reduce bacteria from 
3.7 to 4.7 log CFU/cm2 (Hardin et al., 1995).  LA bactericidal activity is attributed 
to the undissociated molecule of the acid (Ingram et al., 1956).  This causes a 
build up of acid in the cytoplasm of the cell and ends in acidifying the cell’s 
cytoplasm causing death (Booth, 1985; Huffman, 2002).  Gorman et al. (1995) 
reported when sanitizing agents were followed by plain water spray-washing, the 
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effectiveness of the sanitizers was lowered.  They suggested that loss of activity 
was possibly due to the physical removal or dilution of the sanitizing agents.  The 
authors stressed the importance of sequence of interventions including chemical 
sanitizers.  Furthermore, LA effectiveness as a final carcass rinse has shown to 
be reduced, due to the current practice of spray-chilling carcasses, causing a 
dilution of the acid (Pipek et al., 2005).  Dorsa et al. (1998) determined that 2% 
lactic acid spray could effectively suppress the growth of spoilage bacteria, 
Salmonella typhimrium and E. coli O157:H7 stored for 21 days at 4° C.  LA in this 
study was used at ambient temperature (24°-28° C), research has shown that 
elevating LA temperature to 55° C increases effectiveness and reduction of 
spoilage and pathogenic bacteria (Pipek et al., 2005).  Stopforth et al. (2003) 
discovered E. coli O157:H7 formed biofilms and remained detectable (>1.3 log 
CFU/cm2) on stainless steel surfaces, when surfaces were expose to organic 
acid runoff.  A growing concern is that forms of E. coli O157:H7 have adapted to 
acidic concentrations and may arise as a major problem in the future.   
A and MH-A treatments both effectively reduced E. coli O157:H7 to levels 
of 2.0-2.8 log CFU/cm2.  However, A displayed no difference (P> 0.05) in the 
reduction of E. coli O157:H7, from HP15, LA, HP3.  In addition, MH-A displayed 
no difference (P> 0.05) in the reduction of E. coli O157:H7, from MH-NA.  These 
findings, were the first to use Activin that was ESS and used in a multi-hurdle 
approach to combat E. coli O157:H7, and were not consistent with findings of in 
vitro research, where E. coli O157:H7 was reduced by 3 log CFU/cm2 (Jones et 
al. 1992).  Ransom and Belk (2003) found that Activin suppressed growth of E. 
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coli O157:H7 and Listeria monocytogenes in sliced bologna by 0.7-1.3 log and 
6.2 log, respectively.  They also found treatments to beef cuts after inoculation of 
E. coli O157:H7 and Listeria monocytogenes, and stored for 29 d in a vacuum 
bag, showed Activin suppressed growth by 3.3 and 4.7 log, respectively.  Activin 
used in combination with 2% LA was effective in suppressing growth of E. coli 
O157:H7 (1.3 log), Listeria monocytogenes (0.8 log) at 2 days of storage at 12° C 
(Ransom and Belk, 2003).  Locke (2002) observed that application of Activin 
suppressed growth and total plate count numbers during storage.  In the present 
study, treatments containing Activin in Experiment 3 revealed significant (P< 
0.05) suppression of lactic acid bacteria on lean samples treated with MH-A, a 
slight trend (P=0.15) of suppression of Enterobacteriaceae when samples where 
treated with MH-A and a significant difference (P< 0.05) of suppression of 
coliform counts on adipose tissue treated with MH-A compared to MH-NA treated 
samples.  All the findings from the present study, Locke (2002) and Ransom and 
Belk (2003) suggests the possibility Activin may need more time than allotted (20 
seconds and 30 min) by the sequence before rinsing in this study to aid in the 
suppression or reduction of microbial growth.  This could be supported by Naidu 
(2002) were E. coli O157:H7 lost its fimbriae after 2 hrs of exposure to lactoferrin.  
Lactoferrin in Activin has never been tested (only used in a plant setting) in an 
electrostatically spray system, and the molecule could possible undergo a 
conformation change when charged in the system.  Lactoferrin isolated from milk 
becomes highly susceptible to molecular changes resulting from pH, heat, 
proteolysis, ionic imbalance, any of which can greatly decrease its effectiveness 
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as an antimicrobial (Sebranek, 2003).  Charging the protein during ESS possibly 
effects the conformation, iron binding properties, effect its ability to bind to the 
cell surface or binding ability to the meat surface.  Lastly, treatments of hot water 
or organic acid that precedes and/or follows the Activin spray treatment could 
possibly affect its antimicrobial effectiveness.   
 High pressure washes are typically used to physically remove 
decontamination.  HP3 and HP15 both effectively reduced E. coli O157:H7 from 
adipose tissue, and were no more effective at reducing E. coli O157:H7 on 
adipose tissue (P> 0.05) than A, B, and LA treatments.  A concern in the use of 
high pressures has been the possibility of physically driving contamination into 
the muscle and adipose tissues (Groman et al., 1995), and spreading 
contamination from one area of a carcass to another (Barkate et al. 1993).  
DeZuniga et al. (1991) through the use of dye penetration models, recommends 
the maximum pressure used for a spray washing system be 2070 kPa.  Reagen 
et al. (1996) observed less E. coli O157:H7 positives were found on carcasses 
that were washed (410-2758 kPa, 18-39 seconds) compared to carcasses that 
were trimmed or trimmed and washed.  The effectiveness of high pressure 
washes is dependent upon pressure, angle of nozzles, time of exposure and 
temperature of water. 
 Leistner (1995) describes the “hurdle approach” as sequential use of 
decontamination steps.  The sequences if used properly could achieve a 
synergistic effect.  Many studies have tried to quantify this number.  However, 
Gorman et al., (1995), as stated earlier, indicated the use of chemicals before or 
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after washes reduced the effectiveness of washes.  Both MH-A and MH-NA 
sequences effectively reduced E. coli O157:H7, total plate counts, lactic acid 
bacteria, Enterobacteriaceae, and coliform counts in both of the last experiments.  
Elder et al. (2000) reported that in lots sampled before and after multiple 
sequence processes in a plant the E. coli O157:H7 was reduced from 43.4% of 
lots positive to 1.9%.  Bacon et al. (2000) evaluated multiple-sequential 
interventions at eight commercial beef plants and found that E. coli was reduced 
from a range of 2.6–5.3 log CFU/ 100 cm2.  In most cases multiple spray washes 
are more effective than knife trimming on carcasses (Hardin et al., 1995; Dorsa 
et al., 1996; Reagan et al., 1996).  On an interesting note, all treatments in 
experiment 1 had reductions of E. coli O157:H7 on adipose Tissue from 1.6 – 3.0 
log CFU/cm2 and the National Beef multi-hurdle intervention sequence had 2.6-
2.8 log CFU/cm2 reduction on adipose tissue. 
CONCLUSIONS  
All treatments were effective in reducing E. coli O157:H7.  All treatments 
containing Activin did not show an additive reduction against E. coli O157:H7 
when compare to treatments that did not use Activin.  However, multi-hurdle 
sequences that contain Activin had greater suppression of Coliforms and Lactic 
acid bacteria over 7 d of storage. Recommendations of trying different methods 
of application for Activin, and allowing longer exposure times to work on spoilage 
and pathogenic bacteria on carcasses as well as on packaged products should 
be further explored. 
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Figure 2:  Chad Company (Olathe, Ks) Test Wash and Sanitizing Spray Cabinet. 
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Figure 3:  Electrostatic Spray System Test Cabinet, aluminum carcass and spray tower. 
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Figure 5- Mean E. coli O157:H7 counts (Log10 CFU/cm2) attached to beef adipose tissue samples 
inoculated at 1 x 106 CFU/cm2  60, 90, 120, 150, and 180 minutes following hide removal.
a, b, c Mean values with different superscripts are significantly different (P< 0.05).
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Figure 6 – Mean E. coli O157:H7 counts (Log10 CFU/cm2) as affected by spraying/rinsing treatments 
applied to beef adipose tissue samples inoculated at 1 x 106 CFU/cm2.
a, b, c Mean values with different superscripts within a day are significantly different (P< 0.05).
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Table 3 – Mean E. coli O157:H7 counts (Log10 CFU/cm2) as affected by spraying/rinsing 
treatments applied to beef adipose tissue samples inoculated at 1 x 106 CFU/cm2.
a, b, c Mean values with different superscripts within a column are significantly different (P< 0.05)
d Standard Error of the least squares mean
e Least Squares Means  
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Figure 7- Mean E. coli O157:H7 counts (Log10 CFU/cm2) as affected by Multi-Hurdle 
Sequences with Activin (MH-A) and without Activin (MH-NA) applied to beef 
adipose and lean tissue samples inoculated at 1 x 106 CFU/cm2.
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Figure 8- Mean Reduction of Total Plate Counts as affected by Multi-Hurdle Sequences with 
Activin (MH-A) and without Activin (MH-NA) on lean and adipose tissues combined 
following 7 d refrigerated (7°C) storage.
a, b,Mean values with different superscripts are significantly different (P< 0.05).
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Figure 9- Mean Reduction of Colifrom Counts as affected by Multi-Hurdle Sequences with 
Activin (MH-A) and without Activin (MH-NA) on adipose tissue following 7 d refrigerated 
(7°C) storage.
a, b Mean values with different superscripts are significantly different (P< 0.05).
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Figure 10– Mean Reduction of Enterobacteriaceae as affected by Multi-Hurdle Sequences 
with Activin (MH-A) and without Activin (MH-NA) on lean and adipose tissues combined 
following 7 d refrigerated (7°C) storage.
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Figure 11- Mean Reduction of Lactic Acid Bacteria as affected by Multi-Hurdle 
Sequences with Activin (MH-A) and without Activin (MH-NA) on lean and adipose 
tissues combined following 7 d refrigerated (7°C) storage.
a, b, c Mean values in the same tissue type with different superscripts within a column are 
significantly different (P< 0.05).
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Table 4 – Mean Reduction of Lactic Acid Bacteria as affected by Multi-Hurdle 
Sequences with Activin (MH-A) and without Activin (MH-NA) on lean and 
adipose tissues combined following 7 d refrigerated (7°C) storage.
a, b, c Mean values with different superscripts within a column are significantly different (P< 0.05)
d Standard Error of the least squares mean
e Least Squares Means
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HAZARDS ANALYSIS 
AND 
CRITICAL CONTROL POINTS 
 
ACTIVIN  IN-PLANT BEEF CARCASS VALIDATION 
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PROCESS DESCRIPTION 
 
 
PROCESS:   Activin  In-Plant Beef Carcass Validation 
  
1. COMMON NAME ? The Activin Project 
2. HOW IS IT TO BE USED ? A project designed to test the antimicrobial efficacy of 
Activin  against E. Coli 0157:H7. 
3. TYPES OF PACKAGES USED ? Plastic bags (including bio-hazard labeled bags), whirl-pack 
bags, and plastic drums will be used for sample storage 
and/or residual product storage and disposal. 
4. LENGTH OF SHELF LIFE, 
AT WHAT TEMPERATURE ? 
Not applicable 
5. WHERE WILL THE PRODUCT BE SOLD ? All residual products and applicable packaging and 
containers will be condemned and removed by a medical 
waste removal company. 
6. LABELING INSTRUCTIONS ? After research is complete, all products and/or samples will 
be labeled as either “Biohazard” or “Inedible/Condemned”. 
7. IS SPECIAL DISTRIBUTION 
CONTROL NEEDED ? 
Yes, according to the subsequent outline of this plan and the 
written sanitation standard operating procedures for the 
project. 
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PRODUCTS, SUPPLIES and SPECIAL CONSIDERATIONS 
 
 
PROCESS:   Activin  In-Plant Beef Carcass Validation 
 
MEAT MODEL – Beef short plates to represent freshly slaughtered beef carcasses. 
 
CARCASS MODEL – A fabricated aluminum one-dimensional profile of a life-sized beef carcass. 
 
SLAUGHTER FLOOR MODEL – Room 217 of the Food & Ag. Products Center. 
 
TREATMENT MODEL – A stainless steel “spray-cabinet” constructed specifically for this research, which will be set in 
place to represent normal carcass flow through an industry-type spray cabinet. 
 
INOCULUMS – Strains of E. Coli 0157:H7, described in the document titled Activin  In-Plant Carcass Validation 
(Muriana). 
 
TREATMENT – Described in the document titled Activin  In-Plant Carcass Validation (Muriana). 
 
CONTAINMENT – Plastic sheeting will be installed with adhesive tape above and around the spray cabinet to contain 
any aerosolization of inoculum or treatments.  Furthermore, any liquid run-off of inoculums or 
treatments liquids will be collected in a catch-pan and treated to destroy the pathogen, 
before it is released into the environment. 
 
PERSONAL PROTECTIVE EQUIPMENT (PPE) – Described in SSOPs and Microbial Pathogen SOPs. 
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HAZARD  IDENTIFICATION / PREVENTITIVE  MEASURES 
 
 
PROCESS Acti in In Plant Beef Carcass Validation 
 
PROCESS  STEP 
 
HAZARD (B=Biological) 
 
PREVENTIVE 
MEASURES 
Receive Research Supplies No hazards identified 
 
 
Store Research Supplies No hazards identified  
Discard Used Research Supplies B-Supplies may be contaminated with 
the pathogen in use 
B-Sterilize or sanitize contaminated 
supplies and place them in properly 
identified containers for treatment and 
disposal 
Receive Beef Short Plates No hazards identified  
Stage Beef Short Plates No hazards identified  
Inoculate Beef Short Plates B-The environment may become 
contaminated with the pathogen in 
use 
B-Proper control of inoculums 
according to good research practices.  
Also, collection of run-off in a “catch-
pan” 
Treat Beef Short Plates B-The environment may become 
contaminated with the pathogen in 
use due to liquid run-off 
B-Collection of run-off in a “catch-pan” 
Treat Catch Pan B-Inadequate treatment of catch pan B-Sanitizing of catch pan materials 
Excise Samples From Beef Short 
Plates 
B-Equipment used for excisions may 
become contaminated with the 
pathogen in use 
B-Good research practices for work 
with pathogens (Microbial SOPs). 
Package Excised Samples B-Samples in the package will have 
the pathogen present 
B-Proper labeling of packages 
Store Excised Samples B-Samples in the package will have 
the pathogen present 
B-Proper labeling of packages 
Distribute Excised Samples B-Proper labeling of packages B-Proper labeling of packages 
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HAZARD IDENTIFICATION / PREVENTITIVE  MEASURES 
 
 
PROCESS A ti i I Pl t B f C V lid ti
 
PROCESS  STEP 
 
HAZARD (B=Biological) 
 
PREVENTIVE 
MEASURES 
Discard Beef Short Plates in 
Containers 
B-Product in the container may have 
the pathogen present 
B-Proper labeling of the containers 
Clean/Sanitize Beef Short Plates B-Beef short plates may not be 
effectively treated 
B-Follow procedures for 
cleaning/sanitizing the product 
Seal Containers B-Product in the container may have 
the pathogen present 
B-Proper sealing of the container lids 
Distribute Containers to Storage B-The containers may have the 
pathogen present on the outside of 
the container 
B-Sterilize/sanitize outside of 
containers before distribution 
Distribute Containers to Waste 
Removal Company 
B-Product in the container may have 
the pathogen present 
B-Proper labeling of the containers 
   
Receive Pathogen 
(E.Coli 0157:H7) 
B-E. Coli 0157:H7 is a pathogen 
known to cause human illness. 
B-Proper labeling and handling 
according to good research practices 
(Microbial SOPs) 
Store Pathogen B-E. Coli 0157:H7 is a pathogen 
known to cause human illness. 
B-Proper labeling and handling 
according to good research practices 
(Microbial SOPs) 
Prepare Pathogen for Inoculation B-E. Coli 0157:H7 is a pathogen 
known to cause human illness. 
B-Proper labeling and handling 
according to good research practices 
(Microbial SOPs) 
Destroy Residual Pathogen B-Survival of the pathogen B-Proper handling and destruction 
according to good research practices 
(Microbial SOPs) 
Discard the Destroyed Pathogen B-Survival of the pathogen B-Proper handling and destruction 
according to good research practices 
(Microbial SOPs) 
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CCP  DETERMINATION (1 OF 4) 
 
PROCESS:   Activin  In-Plant Beef Carcass Validation 
 
PROCESS STEP 
 
HAZARD (S) 
 
BIOLOGICAL – B 
CHEMICAL – C 
PHYSICAL – P 
 
 
Q1. DO PREVENTITIVE 
MEASURES EXIST FOR 
THE IDENTIFIED 
HAZARDS? 
 
*If no = not a CCP- 
Identify how and where 
This hazard will be 
controlled 
 
*If yes = move to the 
next 
question 
 
Q2. DOES THIS 
PREVENTIVE MEASURE 
ELIMINATE OR REDUCE 
THE LIKELY 
OCCURRENCE OF A 
HAZARD(S) TO AN 
ACCEPTABLE LEVEL? 
 
*If no = move to the next 
question 
 
*If yes = CCP 
 
Q3. COULD 
CONTAMINATION WITH 
IDENTIFIED HAZARDD(S) 
OCCUR IN EXCESS OF 
ACCEPTABLE LEVELS OR 
COULD THESE INCREASE 
TO UNACCEPTABLE 
LEVELS? 
 
*If no = not a CCP 
 
*If yes = move to the next 
question 
 
Q4. WILL A 
SUBSEQUENT STEP 
ELIMINATE THE 
HAZARD(S) OR 
REDUCE THE LIKELY 
OCCURRENCE TO AN 
ACCEPTABLE 
LEVEL? 
 
*If no = CCP 
 
If yes = not a CCP 
 
# CCP 
Receive 
Research 
Supplies 
No hazards identified 
 
     
Store Research 
Supplies 
No hazards identified      
Discard Used 
Research 
Supplies 
B-Supplies may be 
contaminated with the 
pathogen in use 
No – Supplies are certain 
to be contaminated and 
will be handled according 
to SOPs for 
microbiological research 
    
Receive Beef 
Short Plates 
No hazards identified      
Stage Beef Short 
Plates 
No hazards identified      
Inoculate Beef 
Short Plates 
B-The environment 
may become 
contaminated with the 
pathogen in use 
Yes – Control of inoculum 
run-off into a catch pan 
No – While the inoculum is 
collected in a catch pan, it is 
still hazardous 
Yes Yes – treatment of the 
materials in the catch 
pan before released to 
the environment 
 
Treat Beef Short 
Plates 
B-The environment 
may become 
contaminated with the 
pathogen in use due 
to liquid run-off 
Yes – Control and 
collection of the treatment 
and run-off associated 
with the step 
No – While the treatment 
liquids and inoculum are 
collected in a catch pan, it is 
still hazardous 
Yes Yes – treatment of the 
materials in the catch 
pan before released to 
the environment 
 
Treat Catch Pan B – Inadequate 
destruction of 
pathogens in the 
catch pan 
Yes – proper 
concentration and type of 
sanitizer/sterilizer used 
Yes   1 
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CCP  DETERMINATION (2 OF 4) 
 
PROCESS:   Activin  In-Plant Beef Carcass Validation 
 
PROCESS STEP 
 
HAZARD (S) 
 
BIOLOGICAL – B 
CHEMICAL – C 
PHYSICAL – P 
 
 
Q1. DO PREVENTITIVE 
MEASURES EXIST FOR 
THE IDENTIFIED 
HAZARDS? 
 
*If no = not a CCP- 
Identify how and where 
This hazard will be 
controlled 
 
*If yes = move to the 
next 
question 
 
Q2. DOES THIS 
PREVENTIVE MEASURE 
ELIMINATE OR REDUCE 
THE LIKELY 
OCCURRENCE OF A 
HAZARD(S) TO AN 
ACCEPTABLE LEVEL? 
 
*If no = move to the next 
question 
 
*If yes = CCP 
 
Q3. COULD 
CONTAMINATION WITH 
IDENTIFIED HAZARDD(S) 
OCCUR IN EXCESS OF 
ACCEPTABLE LEVELS OR 
COULD THESE INCREASE 
TO UNACCEPTABLE 
LEVELS? 
 
*If no = not a CCP 
 
*If yes = move to the next 
question 
 
Q4. WILL A 
SUBSEQUENT STEP 
ELIMINATE THE 
HAZARD(S) OR 
REDUCE THE LIKELY 
OCCURRENCE TO AN 
ACCEPTABLE 
LEVEL? 
 
*If no = CCP 
 
If yes = not a CCP 
 
# CCP 
Excise Samples 
From Beef Short 
Plates 
B-Equipment used for 
excisions may 
become 
contaminated with 
the pathogen in use 
No – Equipment used is 
certain to be 
contaminated and will be 
handled according to 
SOPs for microbiological 
research 
    
Package Excised 
Samples 
B-Samples in the 
package will have the 
pathogen present 
No – The samples are 
certain to have the 
pathogen present, and 
will be handled according 
to SOPs for 
microbiological research 
    
Store Excised 
Samples 
B-Samples in the 
package will have the 
pathogen present 
No – The samples are 
certain to have the 
pathogen present, and 
will be handled and 
labeled according to 
SOPs for microbiological 
research 
    
Distribute 
Excised Samples 
B-Samples in the 
package will have the 
pathogen present 
No – The samples are 
certain to have the 
pathogen present, and 
will be handled and 
labeled according to 
SOPs for microbiological 
research 
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CCP  DETERMINATION (3 OF 4) 
 
PROCESS:   Activin  In-Plant Beef Carcass Validation 
 
PROCESS STEP 
 
HAZARD (S) 
 
BIOLOGICAL – B 
CHEMICAL – C 
PHYSICAL – P 
 
 
Q1. DO 
PREVENTITIVE 
MEASURES EXIST 
FOR THE 
IDENTIFIED 
HAZARDS? 
 
*If no = not a CCP- 
Identify how and 
where 
This hazard will be 
controlled 
 
*If yes = move to the 
next 
question 
 
Q2. DOES THIS 
PREVENTIVE 
MEASURE ELIMINATE 
OR REDUCE THE 
LIKELY OCCURRENCE 
OF A HAZARD(S) TO 
AN ACCEPTABLE 
LEVEL? 
 
*If no = move to the 
next question 
 
*If yes = CCP 
 
Q3. COULD 
CONTAMINATION WITH 
IDENTIFIED 
HAZARDD(S) OCCUR IN 
EXCESS OF 
ACCEPTABLE LEVELS 
OR COULD THESE 
INCREASE TO 
UNACCEPTABLE 
LEVELS? 
 
*If no = not a CCP 
 
*If yes = move to the 
next question 
 
Q4. WILL A 
SUBSEQUENT 
STEP ELIMINATE 
THE HAZARD(S) 
OR REDUCE THE 
LIKELY 
OCCURRENCE TO 
AN ACCEPTABLE 
LEVEL? 
 
*If no = CCP 
 
If yes = not a CCP 
 
# CCP 
Sanitize Beef Short 
Plates 
B-Beef short 
plates may not be 
effectively treated 
No-The sanitization of 
the beef short plates is 
a precautionary 
measure to help 
reduce the presence 
of the pathogen.  The 
plates will still be 
labeled and handled 
as if they have live 
pathogens present on 
the surface 
    
Discard Beef Short 
Plates in Containers 
B-Product in the 
container may 
have the pathogen 
present 
No – The plates are 
certain to have the 
pathogen present, and 
will be handled and 
labeled as 
“condemned”, 
“inedible”, and 
“biohazard”. 
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Seal Containers B-Product in the 
container may 
have the pathogen 
present 
No – The containers 
are certain to have the 
pathogen present, and 
will be handled and 
labeled as 
“condemned”, 
“inedible”, and 
“biohazard”. 
    
Distribute Containers to 
Storage 
B-The containers 
may have the 
pathogen present 
on the outside of 
the container 
Yes – Sanitizing of the 
outside of the 
containers after they 
are sealed 
Yes   2 
92 
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CCP  DETERMINATION (4 OF 4) 
 
PROCESS:   Activin  In-Plant Beef Carcass Validation 
 
PROCESS STEP 
 
HAZARD (S) 
 
BIOLOGICAL – B 
CHEMICAL – C 
PHYSICAL – P 
 
 
Q1. DO 
PREVENTITIVE 
MEASURES EXIST 
FOR THE IDENTIFIED 
HAZARDS? 
 
*If no = not a CCP- 
Identify how and 
where 
This hazard will be 
controlled 
 
*If yes = move to the 
next 
question 
 
Q2. DOES THIS 
PREVENTIVE MEASURE 
ELIMINATE OR REDUCE 
THE LIKELY 
OCCURRENCE OF A 
HAZARD(S) TO AN 
ACCEPTABLE LEVEL? 
 
*If no = move to the next 
question 
 
*If yes = CCP 
 
Q3. COULD 
CONTAMINATION WITH 
IDENTIFIED 
HAZARDD(S) OCCUR IN 
EXCESS OF 
ACCEPTABLE LEVELS 
OR COULD THESE 
INCREASE TO 
UNACCEPTABLE 
LEVELS? 
 
*If no = not a CCP 
 
*If yes = move to the next 
question 
 
Q4. WILL A 
SUBSEQUENT 
STEP ELIMINATE 
THE HAZARD(S) 
OR REDUCE THE 
LIKELY 
OCCURRENCE TO 
AN ACCEPTABLE 
LEVEL? 
 
*If no = CCP 
 
If yes = not a CCP 
 
# CCP 
Distribute Containers to 
Waste Removal 
Company 
B-Product in the 
container may 
have the pathogen 
present 
No – The containers 
are certain to have the 
pathogen present, and 
will be handled and 
labeled as 
“condemned”, 
“inedible”, and 
“biohazard”. 
    
Receive Pathogen 
(E.Coli 0157:H7) 
B-E. Coli 0157:H7 
is a pathogen 
known to cause 
human illness. 
No – Pathogens will be 
labeled and handled 
according to SOPs for 
microbiological 
research 
    
Store Pathogen B-E. Coli 0157:H7 
is a pathogen 
known to cause 
human illness. 
No – Pathogens will be 
labeled and handled 
according to SOPs for 
microbiological 
research 
    
Prepare Pathogen for 
Inoculation 
B-E. Coli 0157:H7 
is a pathogen 
known to cause 
human illness. 
No – Pathogens will be 
labeled and handled 
according to SOPs for 
microbiological 
research 
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Destroy Residual 
Pathogen 
B-Survival of the 
pathogen 
Yes – Proper 
destruction methods 
(autoclave) 
Yes   3 
Discard the Destroyed 
Pathogen 
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CRITICAL LIMITS,  MONITORING AND CORRECTIVE ACTIONS 
 
PROCESS:   Activin  In-Plant Beef Carcass Validation 
 
PROCESS 
STEP / CCP 
CRITICAL 
LIMITS 
MONITORING PROCEDURES 
(WHO/WHAT/WHEN/HOW) CORRECTIVE ACTIONS 
Treatment of 
the catch pan 
and materials 
collected by the 
additioin of 
chlorine bleach. 
 
CCP 1 
1000 ppm 
free chlorine 
or 
ammonium 
chloride in 
the run-off 
after the 
addition of 
either 
chlorine 
bleach or 
ammonium 
chloride 
1. Who – person assigned to 
the task by the MPM. 
2. What – measure the amount 
of free chlorine in the liquid 
run-off after the addition of 
chlorine bleach. 
3. When – before every time 
the contents of the catch 
pan are released to the 
environment (floor drain). 
4. How – by using Quantofix  
or similar brand test sticks 
for chlorine quantitative 
determinations. 
1. Identify the cause of 
the problem. 
2. Bring the problem 
under control. 
3. Take action to prevent 
re-occurrence. 
4. Retain product until 
corrected. 
Distribute 
containers to 
storage – 
complete and 
proper 
sanitizing (by 
means of 
flooding with 
electric pump) 
before 
distribution 
 
CCP 2 
1000 ppm 
of chlorine 
or 
ammonium 
chloride 
sanitizer 
1. Who – person assigned to 
the task by the MPM. 
2. What – record the amount of 
concentrated sanitizer and 
water used to formulate the 
sanitizer. 
3. When – each occurrence 
when sanitizer is formulated. 
4. How – by observing the 
measurement and addition 
of each ingredient and 
recording the observations. 
1. Identify the cause of the 
problem. 
2. Bring the problem under 
control. 
3. Take action to prevent 
re-occurrence. 
4. Retain product until 
corrected. 
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CRITICAL LIMITS,  MONITORING AND CORRECTIVE ACTIONS 
 
PROCESS:   Activin  In-Plant Beef Carcass Validation 
 
PROCESS 
STEP / CCP 
CRITICAL 
LIMITS 
MONITORING PROCEDURES 
(WHO/WHAT/WHEN/HOW) 
CORRECTIVE 
ACTIONS 
Submit and destroy 
residual pathogens 
by use of autoclave 
 
CCP 3 
Autoclave 
containers of 
residual 
pathogens at 
>121oC, 
at 
15 psi, 
and for 
30 minutes or 
longer  
1. Who – FAPC pathogens laboratory 
personnel. 
2. What – Autoclave the product and print 
the results. 
3. When – each occurrence when 
pathogens remain after the project. 
4. How – by following autoclaving SOPs. 
1. Identify the 
cause of the problem 
2. Bring the problem 
under control 
3. Take action to 
prevent re-
occurrence 
4. Retain product 
until corrected 
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RECORD  KEEPING  AND  VERIFICATION 
 
 
PROCESS:   Activin  In-Plant Beef Carcass Validation 
 
PROCESS  STEP / CCP 
 
RECORDS 
 
VERIFICATION 
PROCEDURESØ 
Treatment of the catch pan and 
materials collected – proper sanitizing 
concentration 
 
CCP 1 
Sanitizer test sticks (strips) – to be attached to 
test stick form with proper identification 
 
1. Direct observation 
of monitoring 
procedures – once 
per day 
2. Verification of 
sanitizer 
concentration with 
test sticks against 
a know 
concentration – 
once per day 
3. Review monitoring 
records – once per 
day 
Distribute containers to storage – 
proper sanitizing before distribution 
 
CCP 2 
Sanitizer concentration formulation sheet for 
CCP2 1. Direct observation 
of monitoring 
procedures – once 
per day 
2. Verification of 
sanitizer 
concentration with 
test sticks against 
a know 
concentration – 
once per day 
3. Review monitoring 
records – once per 
day 
Destroy residual pathogens 
 
CCP 3 
Autoclave record form and autoclave print-out  Use of autoclave tape. 
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Appendix C 
 
 
 
 
SPECIAL SANITATION STANDARD OPERATING PROCEDURES 
 
FOR THE 
 
ACTIVIN  IN-PLANT BEEF CARCASS VALIDATION PROJECT 
 
 
Establishment 526, Stillwater, OK is a part of the Oklahoma 
Food and Agricultural Products Research and Technology 
Center (FAPC). It is a very small slaughter and processing 
establishment for live cattle, hogs and sheep, and 
processes wholesale & retail cuts, ground meats and cured 
and ready to eat meat products. 
 
Management structure is: 
 
Director, FAPC:.....................Dr. J. Roy Escoubas 
Meat Processing Manager (MPM):.............Jacob Nelson 
Meat Processing Coordinator (MPC):.......Russell Nabors 
Pilot Plant Manager (PPM):....................David Moe 
 
The FAPC is participating in special research activities 
for testing the efficacy of an anti-microbial treatment 
against E. Coli 0157:H7.  This research will partially be 
conducted on the slaughter floor of the establishment.  
Because the eventual and subsequent slaughter and 
processing of animals will occur in the establishment when 
the research is concluded, special precautions and 
procedures are defined in this document to ensure proper 
sanitary conditions and to prevent cross-contamination of 
other areas in the establishment.  Procedures for 
conducting the research and control of the pathogen (E. 
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Coli 0157:H7) are outlined in a HACCP plan written 
specifically for the research project. 
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I. PRE-OPERATIONAL PROCEDURES 
 
Objective 1: Rooms 217, 228, 233, 235 and the inedible 
corridor will be used during the research, and 
will be segregated from the remainder of the 
plant. 
 
Objective 2: All equipment, detergents and sanitizers used 
during active research and for final cleaning 
of the area will be prepared and placed in room 
217 before the daily research begins. 
 
Task(s) performed by: Employees of the meat pilot plant, or 
others as directed by the MPM. 
 
A. Post signs indicating entry restrictions.  
 1. Post “No Entry” signs on the following nine (9) 
doors using signs provided and yellow caution 
tape.  Signs and tape will be stored in room 207 
in a box labeled “Activin Project”.  (See 
attached floor plan).  
a. Entry into 217 from 217A. 
b. Entry into 216 from corridor near 215. 
c. Entry into 216 from North exterior entrance. 
d. Entry into 235 from corridor near 234. 
e. Entry into inedible corridor from corridor 
near 234. 
f. Entry into inedible corridor from 231. 
g. Entry into inedible corridor from 230B. 
h. Entry into 217 from 229. 
i. Entry into 228 from corridor near 227. 
 
B. Seal doorways  
 1. Use plastic sheeting (e.g. – Visqueen or similar 
brand/style) and a strong adhesive tape (e.g. – 
3M Brand gray ‘Duck Tape’), to cover and seal 
the doorways at the following eight (8) 
locations and descriptions.  Plastic sheeting 
and tape will be stored in room 207 in boxes 
labeled “Activin Project”.  (See attached floor 
plan for details).  
a. North side of doorway between 217 and 217A. 
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b. West side of doorway between 216 and the 
corridor near 215. 
c. North side of doorway between 235 and the 
corridor near 234. 
d. East side of doorway entry to the inedible 
corridor near 234. 
e. East entry into 231.  Note – disconnect 
electrical power to door opener before sealing 
door. 
f. East entry into 230B. 
g. East entry into 229. 
h. East side of entry into corridor from 228. 
 
C. Prepare sanitation materials.  
1. Cleaning materials – place the following in room 
217.  
a. Foaming machine with 25-foot air hose. 
b. One (1) gallon of normally used detergent 
(Liquik 5 or 20). 
c. One (1) gallon of chlorine bleach (5.25% 
sodium hypochlorite). 
d. Two (2) scrub brushes (red bristles). 
e. Five (5) green scour pads. 
f. Two (2) floor scrub brushes (red handle). 
g. Two (2) containers labeled “Trash” with liners 
installed. 
h. Paper towel rolls in dispensers provided. 
i. Hand soap in dispensers provided. 
 
2. Sanitizing materials – place the following in 
room 217.  
a. Sanitizing canister with 50-foot air hose. 
b. Hand-held siphon gun. 
c. Electric pump with pick-up and discharge hose. 
d. One (1) empty plastic 1-gallon container (for 
preparing sanitizer). 
e. One (1) empty 55-gallon plastic drum. 
f. Two (2) plastic graduated cylinders (10ml 
maximum and 50ml maximum). 
g. One (1) squirt-style pump to fit 1-gallon 
container.  
h. Four (4) gallons of quaternary ammonia. 
i. Two (2) additional gallons of chlorine bleach 
(5.25% sodium hypochlorite). 
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j. Test strip kits for chlorine and quaternary 
ammonia. 
k. Two (2) rubber foot baths (see II., A., 1., 
a.). 
l. Two (2) hand-dip containers (see II., A., 1., 
a.). 
 
 
II. OPERATIONAL PROCEDURES 
 
Objective: Personal hygiene and personnel traffic flow will 
be controlled in a manner to prevent 
contamination of other areas in the 
establishment. 
 
Task(s) performed by: Research participants and employees of 
the establishment, as assigned by the 
project manager or MPM. 
 
 A. While research is actively conducted:   
1. Research participants and employees providing 
assistance will clean and/or sanitize their 
hands, arms, gloves, outer garments, boots, 
etc., or change any garments as often as 
necessary during research operations to maintain 
sanitary conditions.  Special attention must be 
given for those employees that must leave the 
rooms or establishment for retrieving products 
or other needed supplies. 
 
a. Rubber foot bath mats and the hand dip 
containers shall contain a 1000 ppm 
solution of ammonium chloride sanitizer, to 
be changed as often as necessary if they 
become soiled. 
 
2. Research participants will only enter and leave 
room 217 through the main East entrance, or 
through the inedible corridor through rooms 233 
and 235. 
 
 
III. POST OPERATIONAL PROCEDURES 
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Objective 1: At the conclusion of research activities for 
each day, rooms 217, 228, 233, 235, the 
inedible corridor, and all equipment used for 
the research will be cleaned, sanitized and 
restored to its original condition. 
 
Objective 2: At the conclusion of cleaning and sanitizing 
procedures, rooms 217, 228, 233, 235, the 
inedible corridor, and all equipment used for 
the research will be tested for the presence of 
E. Coli 0157:H7. 
 
Task(s) performed by: Employees of the establishment as 
directed by the MPM. 
 
 A. Dress appropriately.  
1. Employees should wear.  
a. Typical slaughter coveralls. 
b. Rubber boots. 
c. Nitrile aprons. 
d. Nitrile gloves. 
e. Other attire normally required by existing 
SOPs and GMPs. 
f. Other attire required by microbiological 
SOPs. 
 
 B. Perform dry clean-up.  
1. Collect all trash items and place in appropriate 
containers. 
2. Collect any residual meat items from floor, 
equipment, etc. and place in appropriate 
containers. 
3. Seal containers with lids and store in room 233. 
 
C. Perform wet clean-up.  
2. Rinse all equipment used and soiled areas with 
hot water (>180oF). 
3. Prepare foaming machine according to normal 
procedure. 
4. Apply foam to all equipment used (including 
water hoses, doors, sinks, etc.) and other 
soiled areas per normal procedure. 
5. Scrub soiled areas with brushes and green pads 
per normal procedure. 
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6. Rinse all areas with hot water (>180oF).  
a. Inspect and re-clean if necessary. 
b. Rinse all areas again with hot water (>180oF) 
if necessary.  
7. Empty foaming machine. 
8. Rinse foaming machine, brushes, air hoses, water 
hoses, and green scour pads with hot water 
(>180oF), and leave exposed for subsequent 
sanitizing procedures. 
 
D. Sanitize  
1. Prepare 50-gallon batches (as many as needed to 
perform the task) of chlorine sanitizer with a 
concentration of 1000 ppm sodium hypochlorite. 
2. Using the electric pump, flood entire area 
(equipment, floors, walls, doors, etc.) with 
chlorine sanitizer.  
 a. Allow areas to remain wet for 15 min. 
minimum.  
3. Rinse entire area with hot water (>180oF). 
4. Prepare 2 gallons of 1000 ppm ammonium chloride 
sanitizer.  
 a. Use siphon gun to sanitize cleaning 
equipment (foaming machine, brushes, green 
pads, air hoses, etc, paper towel dispensers 
and hand soap dispensers, employee garments 
(rubber aprons, rubber boots). 
 
5. Prepare sanitizing canister with 200 ppm 
ammonium chloride sanitizer, and fog room 217. 
 
E. Perform microbial sampling.  
1. Collect samples from the environment and test 
for the presence of E. Coli 0157:H7, according 
to the procedures outlined by the Activin 
Environmental Sampling Program (to be drafted 
and performed by a third-party auditor [Food 
ProTech, Stillwater, OK]). 
2. Record results of the microbial tests on form 
“Activin Environmental Sampling Results”.  
    105 
 a. No processing shall occur in the rooms used 
until test results demonstrate the absence of E. 
Coli 0157:H7 from the environment. 
 
F. Restore rooms.  
1. Remove plastic sheeting and tape, and discard in 
waste receptacles. 
2. Remove “No Entry” signs and store 
3. Remove cleaning equipment to storage 
 
 
IV. MONITORING AND RECORD KEEPING 
 
Objective: Procedures will be monitored and the results 
recorded. 
 
A. The MPM or other assigned personnel will perform 
daily inspection (when applicable) during and after 
post-operational cleaning and sanitizing.  The 
assigned person will use this document as a “check-
list” to perform the inspections.  The results of 
the inspection will be recorded on form “Activin 
M.L.1”.  
1. If the MPM or other assigned personnel determine 
that the procedures are not followed, or 
equipment and rooms are out of compliance, 
corrective and preventive actions will be 
performed.  The actions performed will be 
recorded on form “Activin M.L.1”. 
 
B. According to (III) (E) (1) & (2) of this document, 
the third-party auditor will record and submit to 
the establishment the findings of the environmental 
microbial sampling plan.  Establishment management 
will maintain these reports. 
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V. SANITIZER PREPARATIONS 
 
Objective:  To prepare the proper concentrations of 
sanitizer to meet the requirements of this document. 
 
Task(s) performed by:  Establishment employees as directed 
by the MPM. 
 
 Bi-Quat 
(5.0% / 
5.0%) 
Chlorine Bleach 
(5.25%) 
 
Water 
Chlorine, 
1000 ppm 
-- 3.6 liters or 
(1.0 gallons) 
50 
gallons 
Ammonium 
chloride, 1000 
ppm 
38.0 ml -- 1 gallon 
Ammonium 
chloride, 200 
ppm 
7.5 ml -- 1 gallon 
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ACTIVIN M.L.1 – SSOP INSPECTION REPORT 
 
 
NAME _________________ DATE  
 
1.  Were all items described in the SSOP in place and 
executed correctly? 
 
   Yes         
   No 
 
 
2. If No, cite the section of this document in violation 
 (Example: I. C. 2. d.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Describe below the corrective actions performed. 
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Appendix D 
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Appendix E
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Appendix  F 
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Appendix G 
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Appendix H 
 
Metals’ specifications of water for proper activation of lactoferrin (ALF Ventures, 
2005). 
 
Metal  Spec. 
(ppm) 
Metal Spec. 
(ppm) 
Aluminum <0.1 Magnesium <1 
Antimony <0.1 Manganese <0.01 
Arsenic <0.1 Mercury <0.005 
Barium <0.1 Molybdenum <0.02 
Beryllium <0.01 Nickel <0.1 
Cadmium <0.01 Potassium <0.5 
Calcium <5 Selenium <0.1 
Chromium <0.01 Silver <0.01 
Cobalt <0.04 Sodium <10 
Copper <0.1 Thallium <0.1 
Iron <0.1 Vanadium <0.1 
Lead <0.05 Zinc <0.3 
 
Physical specifications of water for proper activation of lactoferrin (ALF Ventures, 
2005). 
 
Physical Spec. (ppm) 
pH 5.0 - 6.7 
Hardness <6 
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Inorganic Specifications of water for proper activation of lactoferrin (ALF 
Ventures, 2005). 
 
Inorganic Spec. (ppm) 
Total Cyanide <0.1 
Chloride <1 
Fluoride <0.1 
Nitrogen, Nitrite <0.5 
Ortho- phosphate <0.1 
Phosphate <0.1 
Sulfate <1 
 
Microbiological Specifications of water proper activation of lactoferrin (ALF 
Ventures, 2005). 
 
Media Spec. (CFU/100 mL) 
Total Plate Counts < 1 
Coliform Counts < 0.1 
E. coli 0 
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